<SEC-DOCUMENT>0000950103-25-015556.txt : 20251201
<SEC-HEADER>0000950103-25-015556.hdr.sgml : 20251201
<ACCEPTANCE-DATETIME>20251201165036
ACCESSION NUMBER:		0000950103-25-015556
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251201
DATE AS OF CHANGE:		20251201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251540348

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251540349

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp238184_424b2-us25a0907d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center; font-size: 10pt; color: red">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 47%">
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">November 26, 2025</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Medium-Term Senior Notes, Series
    N</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Pricing Supplement No. 2025-USNCH29488</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement Nos. 333-270327
    and 333-270327-01</P></TD></TR>
  </TABLE>
<P STYLE="color: #59AE43; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Autocallable Contingent Coupon Equity Linked Securities
Linked to the Worst Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the S&amp;P 500<SUP>&reg;</SUP>
Equal Weight Index Due November 30, 2028</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&squarf;</TD><TD>The securities offered by this pricing supplement are unsecured
debt securities issued by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc. The securities offer the potential
for periodic contingent coupon payments at an annualized rate that, if all are paid, would produce a yield that is generally higher than
the yield on our conventional debt securities of the same maturity. In exchange for this higher potential yield, you must be willing
to accept the risks that (i) your actual yield may be lower than the yield on our conventional debt securities of the same maturity because
you may not receive one or more, or any, contingent coupon payments, (ii) the value of what you receive at maturity may be significantly
less than the stated principal amount of your securities, and may be zero, and (iii) the securities may be automatically called for redemption
prior to maturity beginning on the first potential autocall date specified below. Each of these risks will depend solely on the performance
of the <B>worst performing</B> of the underlyings specified below.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&squarf;</TD><TD>You will be subject to risks associated with <U>each</U> of
the underlyings and will be negatively affected by adverse movements in <U>any one</U> of the underlyings. Although you will have downside
exposure to the worst performing underlying, you will not receive dividends with respect to any underlying or participate in any appreciation
of any underlying.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&squarf;</TD><TD>Investors in the securities must be willing to accept (i) an
investment that may have limited or no liquidity and (ii) the risk of not receiving any payments due under the securities if we and Citigroup
Inc. default on our obligations. <B>All payments on the securities are subject to the credit risk of Citigroup Global Markets Holdings
Inc. and Citigroup Inc.</B></TD>
</TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD STYLE="width: 80%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 20%; border-right: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlyings:</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Initial underlying value<SUP>*</SUP></B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Coupon barrier value<SUP>**</SUP></B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final barrier value<SUP>***</SUP></B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Nasdaq-100 Index<SUP>&reg;</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">25,236.94</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">18,927.705</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">16,404.011</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Russell 2000<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2,486.116</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1,864.587</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1,615.975</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">7,705.54</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">5,779.155</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">5,008.601</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 80%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>*</SUP>For each underlying, its closing value on the pricing date</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>**</SUP>For each underlying, 75.00% of its initial underlying value</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">***For each underlying, 65.00% of its initial underlying value</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">November 26, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">December 2, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Valuation dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">February 26, 2026, May 26, 2026, August 26, 2026, November 27, 2026, February 26, 2027, May 26, 2027, August 26, 2027, November 26, 2027, February 28, 2028, May 26, 2028, August 28, 2028 and November 27, 2028 (the &ldquo;final valuation date&rdquo;), each subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Unless earlier redeemed, November 30, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon payment dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The third business day after each valuation date, except that the contingent coupon payment date following the final valuation date will be the maturity date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">On each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon equal to 2.1625% of the stated principal amount of the securities (equivalent to a contingent coupon rate of 8.65% per annum) <B>if and only if</B> the closing value of the worst performing underlying on the immediately preceding valuation date is greater than or equal to its coupon barrier value. <B>If the closing value of the worst performing underlying on any valuation date is less than its coupon barrier value, you will not receive any contingent coupon payment on the immediately following contingent coupon payment date. If the closing value of the worst performing underlying on one or more valuation dates is less than its coupon barrier value and, on a subsequent valuation date, the closing value of the worst performing underlying on that subsequent valuation date is greater than or equal to its coupon barrier value, your contingent coupon payment for that subsequent valuation date will include all previously unpaid contingent coupon payments (without interest on amounts previously unpaid). However, if the closing value of the worst performing underlying on a valuation date is less than its coupon barrier value and the closing value of the worst performing underlying on each subsequent valuation date up to and including the final valuation date is less than its coupon barrier value, you will not receive the unpaid contingent coupon payments in respect of those valuation dates.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
    you will receive at maturity for each security you then hold (in addition to the final contingent coupon payment, if applicable):</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT>If
    the final underlying value of the worst performing underlying on the final valuation date is <B>greater than or equal to</B> its final
    barrier value: $1,000</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT>If
    the final underlying value of the worst performing underlying on the final valuation date is <B>less than</B> its final barrier value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">$1,000 + ($1,000 &times; the underlying return of the worst
    performing underlying on the final valuation date)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not automatically redeemed prior to maturity
    and the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier value, you
    will receive significantly less than the stated principal amount of your securities, and possibly nothing, at maturity, and you will not
    receive any contingent coupon payment at maturity (including any previously unpaid contingent coupon payments).</B></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 28%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Proceeds to issuer<SUP>(3)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$18.50</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$981.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$2,615,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$48,377.50</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$2,566,622.50</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><I>(Key Terms continued on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) On the date of this pricing supplement, the estimated value of the
securities is $975.40 per security, which is less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s
proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates,
nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time
after issuance. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) CGMI will receive an underwriting fee of up to $18.50 for each security
sold in this offering. The total underwriting fee and proceeds to issuer in the table above give effect to the actual total underwriting
fee. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a variable selling concession of up to $17.50
for each security they sell and a structuring fee of up to $1.00 for each security they sell. For more information on the distribution
of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting fee,
CGMI and its affiliates may profit from hedging activity related to this offering, even if the value of the securities declines. See &ldquo;Use
of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(3) The per security proceeds to issuer indicated above represent the
minimum per security proceeds to issuer for any security, assuming the maximum per security underwriting fee. As noted above, the underwriting
fee is variable.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-6.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities or determined that this pricing supplement and the accompanying
product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete. Any representation to the contrary
is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, underlying supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks
below:</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: rgb(89,174,67)"><B>Product Supplement No. EA-04-10 dated March 7, 2023</B></FONT></A></TD>
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying Supplement No. 11 dated March 7, 2023</B></FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE43"><B><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67); text-decoration: underline">Prospectus Supplement and Prospectus each dated March 7, 2023</A></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Automatic early redemption:</B></FONT></TD>
    <TD STYLE="width: 77%"><FONT STYLE="font-size: 10pt">If, on any potential autocall date, the closing value of the worst performing underlying on that potential autocall date is greater than or equal to&nbsp;&nbsp;its initial underlying value, each security you then hold will be automatically called on that potential autocall date for redemption on the immediately following contingent coupon payment date for an amount in cash equal to $1,000.00 <I>plus</I> the related contingent coupon payment. <B>The automatic early redemption feature may significantly limit your potential return on the securities. If the worst performing underlying performs in a way that would otherwise be favorable, the securities are likely to be automatically called for redemption prior to maturity, cutting short your opportunity to receive contingent coupon payments. The securities may be automatically called for redemption as early as the first potential autocall date specified below.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Potential autocall dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The valuation dates scheduled to occur on May 26, 2026, August 26, 2026, November 27, 2026, February 26, 2027, May 26, 2027, August 26, 2027, November 26, 2027, February 28, 2028, May 26, 2028 and August 28, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For each underlying, its closing value on the final valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Worst performing underlying:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For any valuation date, the underlying with the lowest underlying return determined as of that valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">For each underlying on any valuation date, (i) its closing value on that valuation date <I>minus</I> its initial underlying value, <I>divided by</I> (ii) its initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">17331BW54 / US17331BW549</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Information</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the securities are set forth in the accompanying product
supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the accompanying
product supplement contains important information about how the closing value of each underlying will be determined and about adjustments
that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events with respect
to each underlying. The accompanying underlying supplement contains information about each underlying that is not repeated in this pricing
supplement. It is important that you read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus
together with this pricing supplement in connection with your investment in the securities. Certain terms used but not defined in this
pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Examples</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples in the first section below illustrate how to determine
whether a contingent coupon will be paid (and whether any previously unpaid contingent coupon payments will be paid) and whether the securities
will be automatically called for redemption following a valuation date that is also a potential autocall date. The examples in the second
section below illustrate how to determine the payment at maturity on the securities, assuming the securities are not automatically redeemed
prior to maturity. The examples are solely for illustrative purposes, do not show all possible outcomes and are not a prediction of any
payment that may be made on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying values, coupon barrier values or final barrier values of the underlyings. For the actual
initial underlying value, coupon barrier value and final barrier value of each underlying, see the cover page of this pricing supplement.
We have used these hypothetical values, rather than the actual values, to simplify the calculations and aid understanding of how the securities
work. However, you should understand that the actual payments on the securities will be calculated based on the actual initial underlying
value, coupon barrier value and final barrier value of each underlying, and not the hypothetical values indicated below. For ease of analysis,
figures below have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 25%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical initial underlying value</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical coupon barrier value</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical final barrier value</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Nasdaq-100 Index<SUP>&reg;</SUP></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">75.00 (75.00% of its hypothetical initial underlying value)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">65.00 (65.00% of its hypothetical initial underlying value)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Russell 2000<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">75.00 (75.00% of its hypothetical initial underlying value)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">65.00 (65.00% of its hypothetical initial underlying value)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">75.00 (75.00% of its hypothetical initial underlying value)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">65.00 (65.00% of its hypothetical initial underlying value)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of Contingent Coupon Payments
and any Payment upon Automatic Early Redemption Following a Valuation Date that is also a Potential Autocall Date</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The three hypothetical examples below illustrate how to determine whether
a contingent coupon will be paid and whether the securities will be automatically redeemed following a hypothetical valuation date that
is also a potential autocall date, assuming that the closing values of the underlyings on the hypothetical valuation date are as indicated
below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical closing value of the Nasdaq-100 Index<SUP>&reg;</SUP> on hypothetical valuation date</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical closing value of the Russell 2000<SUP>&reg;</SUP> Index on hypothetical valuation date</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical closing value of the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index on hypothetical valuation date</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical payment per $1,000.00 security on related contingent coupon payment date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Example 1<BR>
Hypothetical Valuation Date #1</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120<BR>
(underlying return =<BR>
(120 - 100) / 100 = 20%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">85<BR>
(underlying return =<BR>
(85 - 100) / 100 = -15%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100<BR>
(underlying return =<BR>
(100 - 100) / 100 = 0%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>$21.625</B><BR>
(contingent coupon is paid; securities not redeemed)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Example 2<BR>
Hypothetical Valuation Date #2</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45<BR>
(underlying return =<BR>
(45 - 100) / 100 = -55%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120<BR>
(underlying return =<BR>
(120 - 100) / 100 = 20%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">130<BR>
(underlying return =<BR>
(130 - 100) / 100 = 30%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>$0.00</B><BR>
(no contingent coupon; securities not redeemed)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Example 3<BR>
Hypothetical Valuation Date #3</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125<BR>
(underlying return =<BR>
(125 - 100) / 100 = 25%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115<BR>
(underlying return =<BR>
(115 - 100) / 100 = 15%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110<BR>
(underlying return =<BR>
(110 - 100) / 100 = 10%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>$1,043.25</B><BR>
(contingent coupon <I>plus</I> the previously unpaid contingent coupon is paid; securities redeemed)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 1:</B></FONT> On hypothetical
valuation date #1, the Russell 2000<SUP>&reg;</SUP> Index has the lowest underlying return and, therefore, is the worst performing underlying
on the hypothetical valuation date. In this scenario, the closing value of the worst performing underlying on the hypothetical valuation
date is greater than its coupon barrier value but less than its initial underlying value. As a result, investors in the securities would
receive the contingent coupon payment on the related contingent coupon payment date and the securities would not be automatically redeemed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 2:</B></FONT> On hypothetical
valuation date #2, the Nasdaq-100 Index<SUP>&reg;</SUP> has the lowest underlying return and, therefore, is the worst performing underlying
on the hypothetical valuation date. In this scenario, the closing value of the worst performing underlying on the hypothetical valuation
date is less than its coupon barrier value. As a result, investors would not receive any payment on the related contingent coupon payment
date and the securities would not be automatically redeemed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive a contingent coupon
on the contingent coupon payment date following a valuation date if the closing value of the worst performing underlying on that valuation
date is less than its coupon barrier value. Whether a contingent coupon is paid following a valuation date depends solely on the closing
value of the worst performing underlying on that valuation date.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 3:</B></FONT> On hypothetical
valuation date #3, the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index has the lowest underlying return and, therefore, is the worst performing
underlying on the hypothetical valuation date. In this scenario, the closing value of the worst performing underlying on the hypothetical
valuation date is greater than both its coupon barrier value and its initial underlying value. As a result, the securities would be automatically
redeemed on the related contingent coupon payment date for an amount in cash equal to $1,000.00 <I>plus</I> the related contingent coupon
payment <I>plus</I> any previously unpaid contingent coupon payments. Because no contingent coupon payment was received in connection
with hypothetical valuation date #2, investors in the securities would also receive the previously unpaid contingent coupon payment on
the related contingent coupon payment date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the hypothetical valuation date were not also a potential autocall
date, the securities would not be automatically redeemed on the related contingent coupon payment date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of the Payment at Maturity
on the Securities</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The next three hypothetical examples illustrate the calculation of the
payment at maturity on the securities, assuming that the securities have not been earlier automatically redeemed and that the final underlying
values of the underlyings are as indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical final underlying value of the Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical final underlying value of the Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical final underlying value of the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical payment at maturity per $1,000.00 security</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Example 4</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110<BR>
(underlying return =<BR>
(110 - 100) / 100 = 10%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120<BR>
(underlying return =<BR>
(120 - 100) / 100 = 20%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">140<BR>
(underlying return =<BR>
(140 - 100) / 100 = 40%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>$1,021.625 <I>plus</I></B> any previously unpaid contingent coupon payments</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Example 5</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110<BR>
(underlying return =<BR>
(110 - 100) / 100 = 10%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110<BR>
(underlying return =<BR>
(110 - 100) / 100 = 10%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">30<BR>
(underlying return =<BR>
(30 - 100) / 100 = -70%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>$300.00</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Example 6</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20<BR>
(underlying return =<BR>
(20 - 100) / 100 = -80%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">85<BR>
(underlying return =<BR>
(85 - 100) / 100 = -15%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">35<BR>
(underlying return =<BR>
(35 - 100) / 100 = -65%)</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>$200.00</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 4:</B></FONT> On the final valuation
date, the Nasdaq-100 Index<SUP>&reg;</SUP> has the lowest underlying return and, therefore, is the worst performing underlying on the
final valuation date. In this scenario, the final underlying value of the worst performing underlying on the final valuation date is greater
than its final barrier value and its coupon barrier value. Accordingly, at maturity, you would receive the stated principal amount of
the securities <I>plus</I> the contingent coupon payment due at maturity (assuming no previously unpaid contingent coupon payments), but
you would not participate in the appreciation of any of the underlyings.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 5:</B></FONT> On the final valuation
date, the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index has the lowest underlying return and, therefore, is the worst performing underlying
on the final valuation date. In this scenario, the final underlying value of the worst performing underlying on the final valuation date
is less than its final barrier value. Accordingly, at maturity, you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000.00 + ($1,000.00 &times; the underlying
return of the worst performing underlying on the final valuation date)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + ($1,000.00 &times; -70.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + -$700.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $300.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value of the worst performing
underlying on the final valuation date is less than its final barrier value, you would lose a significant portion of your investment in
the securities. In addition, because the final underlying value of the worst performing underlying on the final valuation date is below
its coupon barrier value, you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 6:</B></FONT> On the final valuation
date, the Nasdaq-100 Index<SUP>&reg;</SUP> has the lowest underlying return and, therefore, is the worst performing underlying on the
final valuation date. In this scenario, the final underlying value of the worst performing underlying on the final valuation date is less
than its final barrier value. Accordingly, at maturity, you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000.00 + ($1,000.00 &times; the underlying
return of the worst performing underlying on the final valuation date)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + ($1,000.00 &times; -80.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + -$800.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $200.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value of the worst performing
underlying on the final valuation date is less than its final barrier value, you would lose a significant portion of your investment in
the securities. In addition, because the final underlying value of the worst performing underlying on the final valuation date is below
its coupon barrier value, you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>It is possible that the closing value of the worst performing underlying
will be less than its coupon barrier value on each valuation date and less than its final barrier value on the final valuation date, such
that you will not receive any contingent coupon payments over the term of the securities (including any previously unpaid contingent coupon
payments) and will receive significantly less than the stated principal amount of your securities, and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Risk Factors</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with each underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not automatically redeemed prior
to maturity, your payment at maturity will depend on the final underlying value of the worst performing underlying on the final valuation
date. If the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier value,
you will lose 1% of the stated principal amount of your securities for every 1% by which the worst performing underlying on the final
valuation date has declined from its initial underlying value. There is no minimum payment at maturity on the securities, and you may
lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive any contingent coupon on the contingent coupon payment date following any valuation date on which the closing
value of the worst performing underlying on that valuation date is less than its coupon barrier value.</B> A contingent coupon payment
will be made on a contingent coupon payment date if and only if the closing value of the worst performing underlying on the immediately
preceding valuation date is greater than or equal to its coupon barrier value. If the closing value of the worst performing underlying
on any valuation date is less than its coupon barrier value, you will not receive any contingent coupon payment on the immediately following
contingent coupon payment date. You will receive a contingent coupon payment that has not been paid on a subsequent contingent coupon
payment date if and only if the closing value of the worst performing underlying on the related valuation date is greater than or equal
to its coupon barrier value. If the closing value of the worst performing underlying on each valuation date is below its coupon barrier
value, you will not receive any contingent coupon payments over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk.</B> The securities offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing date for the securities, including
the risk that you may not receive a contingent coupon payment on one or more, or any, contingent coupon payment dates and the risk that
the value of what you receive at maturity may be significantly less than the stated principal amount of your securities and may be zero.
The volatility of, and correlation between, the closing values of the underlyings are important factors affecting these risks. Greater
expected volatility of, and lower expected correlation between, the closing values of the underlyings as of the pricing date may result
in a higher contingent coupon rate, but would also represent a greater expected likelihood as of the pricing date that the closing value
of the worst performing underlying on one or more valuation dates will be less than its coupon barrier value, such that you will not receive
one or more, or any, contingent coupon payments during the term of the securities and that the final underlying value of the worst performing
underlying on the final valuation date will be less than its final barrier value, such that you will not be repaid the stated principal
amount of your securities at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to heightened risk because they have multiple underlyings.</B> The securities are more risky than similar
investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any one underlying
will perform poorly, adversely affecting your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs
poorly.</B> You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will be negatively
affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings would
be better than the performance of the worst performing underlying alone. Instead, you are subject to the full risks of whichever of the
underlyings is the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not benefit in any way from the performance of any better performing underlying.</B> The return on the securities depends
solely on the performance of the worst performing underlying, and you will not benefit in any way from the performance of any better performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings.</B> It is preferable from your perspective for
the underlyings to be correlated with each other, in the sense that their closing values tend to increase or decrease at similar times
and by similar magnitudes. By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship.
The less correlated the underlyings, the more likely it is that any one of the underlyings will perform poorly over the term of the securities.
All that is necessary for the securities to perform poorly is for one of the underlyings to perform poorly. It is impossible to predict
what the relationship between the underlyings will be over the term of the securities. The underlyings differ in significant ways and,
therefore, may not be correlated with each other.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the worst performing underlying.</B> The potential contingent
coupon payments on the securities are the compensation you receive for assuming the downside risk of the worst performing underlying,
as well as all the other risks of the securities. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than
you currently anticipate. First, the actual yield you realize on the securities could be lower than you anticipate because the coupon
is &ldquo;contingent&rdquo; and you may not receive a contingent coupon payment on one or more, or any, of the contingent coupon payment
dates. Second, the contingent coupon payments are the compensation you receive not only for the downside risk of the worst performing
underlying, but also for all of the other risks of the securities, including the risk that the securities may be automatically redeemed
prior to maturity, interest rate risk and our and Citigroup Inc.&rsquo;s credit risk. If those other risks increase or are otherwise greater
than you currently anticipate, the contingent coupon payments may turn out to be inadequate to compensate you for all the risks of the
securities, including the downside risk of the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>
The securities may be automatically redeemed prior to maturity, limiting your opportunity to receive contingent coupon payments.</B> On
any potential autocall date, the securities will be automatically called for redemption if the closing value of the worst performing underlying
on that potential autocall date is greater than or equal to its initial underlying value. As a result, if the worst performing underlying
performs in a way that would otherwise be favorable, the securities are likely to be automatically redeemed, cutting short your opportunity
to receive contingent coupon payments. If the securities are automatically redeemed prior to maturity, you may not be able to reinvest
your funds in another investment that provides a similar yield with a similar level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities offer downside exposure to the worst performing underlying, but no upside exposure to any underlying.</B> You will
not participate in any appreciation in the value of any underlying over the term of the securities. Consequently, your return on the securities
will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on any underlying
over the term of the securities. In addition, as an investor in the securities, you will not receive any dividends or other distributions
or have any other rights with respect to any of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The performance of the securities will depend on the closing values of the underlyings solely on the valuation dates, which makes
the securities particularly sensitive to volatility in the closing values of the underlyings on or near the valuation dates.</B> Whether
the contingent coupon will be paid on any given contingent coupon payment date (and whether any previously unpaid contingent coupon payments
will be paid) and whether the securities will be automatically redeemed prior to maturity will depend on the closing values of the underlyings
solely on the applicable valuation dates, regardless of the closing values of the underlyings on other days during the term of the securities.
If the securities are not automatically redeemed prior to maturity, what you receive at maturity will depend solely on the closing value
of the worst performing underlying on the final valuation date, and not on any other day during the term of the securities. Because the
performance of the securities depends on the closing values of the underlyings on a limited number of dates, the securities will be particularly
sensitive to volatility in the closing values of the underlyings on or near the valuation dates. You should understand that the closing
value of each underlying has historically been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between, the closing values of
the underlyings, dividend yields on the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo;
views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models
may prove to be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities
set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">the securities determined for purposes of
a secondary market transaction will be based on our secondary market rate, which will likely result in a lower value for the securities
than if our internal funding rate were used. In addition, any secondary market price for the securities will be reduced by a bid-ask spread,
which may vary depending on the aggregate stated principal amount of the securities to be purchased in the secondary market transaction,
and the expected cost of unwinding related hedging transactions. As a result, it is likely that any secondary market price for the securities
will be less than the issue price.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing values of the underlyings, the volatility of, and correlation between, the closing
values of the underlyings, dividend yields on the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup
Inc.&rsquo;s creditworthiness, as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating
to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based
on many unpredictable factors&rdquo; in the accompanying product supplement. Changes in the closing values of the underlyings may not
result in a comparable change in the value of your securities. You should understand that the value of your securities at any time prior
to maturity may be significantly less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The Russell 2000<SUP>&reg;</SUP> Index is subject to risks associated with small capitalization stocks.</B> The stocks that constitute
the Russell 2000<SUP>&reg;</SUP> Index are issued by companies with relatively small market capitalization. The stock prices of smaller
companies may be more volatile than stock prices of large capitalization companies. These companies tend to be less well-established than
large market capitalization companies. Small capitalization companies may be less able to withstand adverse economic, market, trade and
competitive conditions relative to larger companies. Small capitalization companies are less likely to pay dividends on their stocks,
and the presence of a dividend payment could be a factor that limits downward stock price pressure under adverse market conditions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index may underperform the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index.</B>&nbsp;The
S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index is composed of the same constituents as the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index,
but weights those constituents equally (as rebalanced each quarter) rather than based on market capitalization as in the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index.
As a result, the companies with the largest market capitalizations will have a smaller impact on the performance of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal
Weight Index than on the performance of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index. If larger market capitalization companies outperform
smaller market capitalization companies, then the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index will underperform the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index,
perhaps significantly.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of any underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlyings is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlyings or in
instruments related to the underlyings, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the closing values of the underlyings in a way that
negatively affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of an underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions in the underlyings
or in financial instruments related to the underlyings and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlyings or in financial instruments related to the underlyings on a regular basis (taking long or short
positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers.
These activities could affect the closing values of the underlyings in a way that negatively affects the value of and your return on the
securities. They could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlyings
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to an underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Changes that affect the underlyings may affect the value of your securities.</B> The sponsors of the underlyings may at any time
make methodological changes or other changes in the manner in which they operate that could affect the values of the underlyings. We are
not affiliated with any such underlying sponsor and, accordingly, we have no control over any changes any such sponsor may make. Such
changes could adversely affect the performance of the underlyings and the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.</B> There is no direct legal authority regarding
the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the
&ldquo;IRS&rdquo;). Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might
not agree with the treatment of the securities as described in &ldquo;United States Federal Tax Considerations&rdquo; below. If the IRS
were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the
securities might be materially and adversely affected. Moreover, future legislation, Treasury regulations or IRS guidance could adversely
affect the U.S. federal tax treatment of the securities, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Non-U.S. investors should note that persons having withholding
responsibility in respect of the securities may withhold on any coupon payment paid to a non-U.S. investor, generally at a rate of 30%.
To the extent that we have withholding responsibility in respect of the securities, we intend to so withhold.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">You should read carefully the discussion under &ldquo;United
States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement
and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement. You should also consult your tax adviser regarding
the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under the laws of any state,
local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About the Nasdaq-100 Index<SUP>&reg;</SUP></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Nasdaq-100 Index<SUP>&reg;</SUP> is a modified market capitalization-weighted
index of stocks of the 100 largest non-financial companies listed on the Nasdaq Stock Market. All stocks included in the Nasdaq-100 Index<SUP>&reg;</SUP>
are traded on a major U.S. exchange. The Nasdaq-100 Index<SUP>&reg;</SUP> was developed by the Nasdaq Stock Market, Inc. and is calculated,
maintained and published by Nasdaq, Inc.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;
The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the Nasdaq-100 Index<SUP>&reg;</SUP>
from publicly available information and have not independently verified any information regarding the Nasdaq-100 Index<SUP>&reg;</SUP>.
This pricing supplement relates only to the securities and not to the Nasdaq-100 Index<SUP>&reg;</SUP>. We make no representation as to
the performance of the Nasdaq-100 Index<SUP>&reg;</SUP> over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Nasdaq-100 Index<SUP>&reg;</SUP> is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the Nasdaq-100 Index<SUP>&reg;</SUP> on November
26, 2025 was 25,236.94.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the Nasdaq-100 Index<SUP>&reg;</SUP>
for each day such value was available from January 2, 2015 to November 26, 2025. We obtained the closing values from Bloomberg L.P., without
independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Nasdaq-100 Index<SUP>&reg;</SUP> &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="font-size: 10pt; color: white"><BR>
</FONT></B><B><FONT STYLE="font-size: 10pt; color: #59AE43">January 2, 2015 to November 26, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 320px; width: 577px"></FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About the Russell 2000<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Russell 2000<SUP>&reg;</SUP> Index is designed to track the performance
of the small capitalization segment of the U.S. equity market. All stocks included in the Russell 2000<SUP>&reg;</SUP> Index are traded
on a major U.S. exchange. It is calculated and maintained by FTSE Russell.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;
The Russell Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the Russell 2000<SUP>&reg;</SUP>
Index from publicly available information and have not independently verified any information regarding the Russell 2000<SUP>&reg;</SUP>
Index. This pricing supplement relates only to the securities and not to the Russell 2000<SUP>&reg;</SUP> Index. We make no representation
as to the performance of the Russell 2000<SUP>&reg;</SUP> Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Russell 2000<SUP>&reg;</SUP> Index is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the Russell 2000<SUP>&reg;</SUP> Index on November
26, 2025 was 2,486.116.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the Russell 2000<SUP>&reg;</SUP>
Index for each day such value was available from January 2, 2015 to November 26, 2025. We obtained the closing values from Bloomberg L.P.,
without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Russell 2000<SUP>&reg;</SUP> Index &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="font-size: 10pt; color: white"><BR>
</FONT></B><B><FONT STYLE="font-size: 10pt; color: #59AE43">January 2, 2015 to November 26, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 319px; width: 576px"></FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About the S&amp;P 500<SUP>&reg;</SUP> Equal
Weight Index</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index is the equal-weight
version of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index. The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index includes the same constituents
as the capitalization weighted S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index. The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index is calculated
and maintained by S&amp;P Dow Jones Indices LLC.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Annex A&rdquo; in this pricing supplement
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal
Weight Index from publicly available information and have not independently verified any information regarding the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal
Weight Index. This pricing supplement relates only to the securities and not to the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index.
We make no representation as to the performance of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index is not involved in any
way in this offering and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index
on November 26, 2025 was 7,705.54.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the S&amp;P 500<SUP>&reg;</SUP>
Equal Weight Index for each day such value was available from January 2, 2015 to November 26, 2025. We obtained the closing values from
Bloomberg L.P., without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="font-size: 10pt; color: white"><BR>
</FONT></B><B><FONT STYLE="font-size: 10pt; color: #59AE43">January 2, 2015 to November 26, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 319px; width: 575px"></FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">United States Federal Tax Considerations</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the securities. In connection with any information reporting
requirements we may have in respect of the securities under applicable law, we intend (in the absence of an administrative determination
or judicial ruling to the contrary) to treat the securities for U.S. federal income tax purposes as prepaid forward contracts with associated
coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of
tax accounting. In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions, this treatment
of the securities is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively that
this treatment is more likely than not to be upheld, and that alternative treatments are possible.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Any coupon payments on the securities should be taxable as ordinary income to you at the time received
or accrued in accordance with your regular method of accounting for U.S. federal income tax purposes.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital
gain or loss equal to the difference between the amount realized and your tax basis in the security. For this purpose, the amount realized
does not include any coupon paid on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated
as a coupon payment. Such gain or loss should be long-term capital gain or loss if you held the security for more than one year.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders.</B> Because significant aspects
of the tax treatment of the securities are uncertain, persons having withholding responsibility in respect of the securities may withhold
on any coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the
extent that we have (or an affiliate of ours has) withholding responsibility in respect of the securities, we intend to so withhold. In
order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish
that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult
your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any amounts withheld
and the certification requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially replicate the economic performance
of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations,
as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2025 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the securities and representations provided by us, our counsel is of the opinion that the securities should not
be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any U.S. Underlying
Equity and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Supplemental Plan of Distribution</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of up to $18.50 for each security
sold in this offering. The actual underwriting fee will be equal to the selling concession and structuring fee provided to selected dealers,
as described in this paragraph. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a variable selling
concession of up to $17.50 for each security they sell and a structuring fee of up to $1.00 for each security they sell.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Valuation of the Securities</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Validity of the Securities</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and issued
by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings
Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In addition,
this opinion is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has
been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly
authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of
the securities nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup Global Markets
Holdings Inc. and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result in a violation of
any provision of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable,
or any restriction imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup
Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has
duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup Global
Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and
of the securities offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global
Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation
or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws
of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents submitted to her or such persons
as originals, the conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies
and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.&nbsp;&nbsp;This
opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Contact</P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Annex A </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Description of the S&amp;P 500<SUP>&reg;</SUP>
Equal Weight Index</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index is calculated, maintained
and published by S&amp;P Dow Jones Indices LLC (&ldquo;S&amp;P Dow Jones&rdquo;). All information contained in this pricing supplement
regarding the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index, including, without limitation, its make-up, method of calculation and changes
in its components, has been derived from publicly available information, without independent verification.&nbsp;&nbsp;This information
reflects the policies of, and is subject to change by, S&amp;P Dow Jones.&nbsp;&nbsp;S&amp;P Dow Jones has no obligation to continue to
publish, and may discontinue the publication of, the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index. The securities represent obligations
of Citigroup Global Markets Holdings Inc. (guaranteed by Citigroup Inc.) only. S&amp;P Dow Jones is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index began publishing
on January 8, 2003 and has a base date of December 29, 1989.&nbsp;&nbsp;The price return version of the S&amp;P 500<SUP>&reg;</SUP> Equal
Weight Index is reported by Bloomberg, L.P. under the ticker symbol &ldquo;SPW.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index&nbsp;is
designed to be the size-neutral version of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index. The&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal
Weight Index&nbsp;employs the same eligibility criteria and constituent changes as the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index, and the&nbsp;S&amp;P
500<SUP>&reg;</SUP>&nbsp;Equal Weight Index&nbsp;has the same constituents as the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index. At each quarterly
rebalancing, each constituent of the&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index&nbsp;is allocated the same weight as every
other constituent in the index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Index Construction</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index&nbsp;is
an equal-weighted version of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index. Index composition is the same as the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index.
Constituent changes are incorporated in the&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index as and when they are made in the
S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index. For additional information about the S&amp;P 500<SUP>&reg;</SUP> Index, including the methodology
for inclusion in the S&amp;P 500<SUP>&reg;</SUP> Index, see &ldquo;Equity Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; in
the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">When a company is added to the&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal
Weight Index&nbsp;in the middle of the quarter, it takes the weight of the company that it replaced. The one exception is when a company
is removed from the&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index&nbsp;at a price of $0.00. In such a case, the company&rsquo;s
replacement is added to the index at the weight using the previous day&rsquo;s closing value, or the most immediate prior business day
that the deleted company was not valued at $0.00.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Weighting</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index&nbsp;is
an equal-weighted index, meaning an index where every stock, or company, has the same weight in the index. As stock prices move, the weights
will shift and exact equality will be lost. Therefore, an equal weighted index must be rebalanced from time to time to re-establish the
proper weighting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight Index&nbsp;is
reset to equal weight quarterly after the close of business on the third Friday of March, June, September, and December. The reference
date for weighting is the second Friday of the reweighting month and changes are effective after the close of the following Friday using
prices as of the reweighting reference date, and membership, shares outstanding, and investable weight factors (&ldquo;IWF&rdquo;) as
of the reweighting effective date. For those companies having multiple share class lines in the index, each share class line is assigned
a weight that is proportional to its float-adjusted market capitalization as of the second Friday pricing reference date. Since index
shares are assigned based on prices one week prior to the rebalancing, the actual weight of each company at the rebalancing differs from
the target equal weights due to market movements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Index Calculation</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The overall approach to calculate the value of the&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal
Weight Index&nbsp;is the same as the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index; except that each constituent&rsquo;s market value in the
S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index is multiplied by its additional weight factor (AWF). The AWF is a number used to convert a constituent&rsquo;s
market value in the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index into an equal weight in the&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal Weight
Index&nbsp;at the most recent quarterly rebalancing, while maintaining the total market value of the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index.
Between quarterly rebalancings, the AWFs are fixed and therefore the weights of&nbsp;the constituents in the&nbsp;S&amp;P 500<SUP>&reg;</SUP>&nbsp;Equal
Weight Index&nbsp;will shift as constituent prices increase or decrease. In order to re-establish equal weighting, new AWFs are calculated
on a quarterly basis.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Index Maintenance</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Several types of corporate actions, and their related treatment, are
listed in the table below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border: black 1pt solid; text-align: center"><B>Corporate Action</B></TD>
    <TD STYLE="width: 60%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><B>Treatment</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Company addition/deletion</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><U>Fixed Component Count Index Treatment (Stock Replacements)</U></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The company entering the index goes in at the weight of the company
coming out. If a company is being removed at a price of $0.00, the replacement goes in at the weight of the deleted company at the close
on the day before the effective date. If more than</P></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 60%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">one company is being replaced in the index on a single date, the replacements
    are added in the order specified in the client announcement. There will be no change in index market capitalization and no divisor change
    for stock replacements except where a company is removed at a price of zero as noted above.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><U>Deletion</U></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The weights of all stocks in the index will proportionately change,
due to the absolute change in the number of index constituents. Relative weights will stay the same. The index divisor will change due
to the net change in the index market capitalization</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Change in shares outstanding</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">Shares outstanding changes are offset by an AWF. There is no change to the index market capitalization and no divisor adjustment.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Split/reverse split</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">Shares outstanding are adjusted by split ratio. Stock price is adjusted by split ratio. There is no change to the index market capitalization and no divisor adjustment.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Change in IWF</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">IWF changes are offset by an AWF. There is no change to the index market capitalization and no divisor adjustment.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Special dividend</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">The stock price is adjusted by the amount of the dividend. The net change to the index market capitalization causes a divisor adjustment</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">Rights offering</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid">All rights offerings that are in the money on the ex-date are applied under the assumption the rights are fully subscribed. The stock price is adjusted by the value of the rights and the shares outstanding are increased by the rights ratio. The change in price and shares is offset by an AWF to keep the index market capitalization (stock weight) unchanged. There is no change to the index market capitalization and no divisor adjustment.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Comparison of Historical S&amp;P 500<SUP>&reg;</SUP> Equal Weight
Index Performance Against Historical S&amp;P 500<SUP>&reg;</SUP> Index Performance</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth a comparison of the historical performance
of the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index against the historical performance of the S&amp;P 500<SUP>&reg;</SUP> Index from
January 2, 2015 through November 26, 2025, each normalized to have a closing value of 100.00 on January 2, 2015 to facilitate a comparison.
In the graph below, references to &ldquo;SPW&rdquo; are to the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index and references to &ldquo;SPX&rdquo;
are to the S&amp;P 500<SUP>&reg;</SUP> Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><I><IMG SRC="image_004.jpg" ALT="" STYLE="height: 313px; width: 573px"></I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE OF THE S&amp;P 500<SUP>&reg;</SUP>
EQUAL WEIGHT INDEX&nbsp;AND RELATIVE PERFORMANCE BETWEEN THE S&amp;P 500<SUP>&reg;</SUP> EQUAL WEIGHT INDEX&nbsp;AND THE S&amp;P 500<SUP>&reg;</SUP>
INDEX ARE NOT INDICATIVE OF FUTURE PERFORMANCE</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><B><I>License Agreement</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">S&amp;P Dow Jones and Citigroup Global Markets Inc. have entered into
a non-exclusive license agreement providing for the license to Citigroup Inc. and its other affiliates, in exchange for a fee, of the
right to use indices owned and published by S&amp;P Dow Jones in connection with certain</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">financial products, including the securities. &ldquo;Standard &amp;
Poor&rsquo;s&rdquo; and &ldquo;S&amp;P&rdquo; are trademarks of Standard &amp; Poor&rsquo;s Financial Services LLC (&ldquo;S&amp;P&rdquo;).
&ldquo;Dow Jones&rdquo; is a registered trademark of Dow Jones Trademark Holdings, LLC (&ldquo;Dow Jones&rdquo;). Trademarks have been
licensed to S&amp;P Dow Jones and have been licensed for use by Citigroup Inc. and its affiliates.&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The license agreement between S&amp;P Dow Jones and Citigroup Global
Markets Inc. provides that the following language must be stated in this pricing supplement:&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;The securities are not sponsored, endorsed, sold or promoted
by S&amp;P Dow Jones, Dow Jones, S&amp;P or their respective affiliates (collectively, &ldquo;S&amp;P Dow Jones Indices&rdquo;). S&amp;P
Dow Jones Indices make no representation or warranty, express or implied, to the holders of the securities or any member of the public
regarding the advisability of investing in securities generally or in the securities particularly. S&amp;P Dow Jones Indices&rsquo; only
relationship to Citigroup Inc. and its affiliates (other than transactions entered into in the ordinary course of business) is the licensing
of certain trademarks, trade names and service marks of S&amp;P Dow Jones Indices and of the S&amp;P 500<SUP>&reg;</SUP> Equal Weight
Index, which is determined, composed and calculated by S&amp;P Dow Jones Indices without regard to Citigroup Inc., its affiliates or the
securities. S&amp;P Dow Jones Indices have no obligation to take the needs of Citigroup Inc., its affiliates or the holders of the securities
into consideration in determining, composing or calculating the S&amp;P 500<SUP>&reg;</SUP> Equal Weight Index. S&amp;P Dow Jones Indices
are not responsible for and have not participated in the determination of the timing of, prices at or quantities of the securities to
be issued or in the determination or calculation of the equation by which the securities are to be converted into cash. S&amp;P Dow Jones
Indices have no obligation or liability in connection with the administration, marketing or trading of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>S&amp;P DOW JONES INDICES DO NOT GUARANTEE THE ACCURACY AND/OR THE
COMPLETENESS OF THE S&amp;P 500<SUP>&reg;</SUP> EQUAL WEIGHT INDEX OR ANY DATA INCLUDED THEREIN AND S&amp;P DOW JONES INDICES SHALL HAVE
NO LIABILITY FOR ANY ERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN. S&amp;P DOW JONES INDICES MAKE NO WARRANTY, EXPRESS OR IMPLIED, AS TO
RESULTS TO BE OBTAINED BY CITIGROUP INC., HOLDERS OF THE SECURITIES, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE S&amp;P 500<SUP>&reg;</SUP>
EQUAL WEIGHT INDEX OR ANY DATA INCLUDED THEREIN. S&amp;P DOW JONES INDICES MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIM
ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE S&amp;P 500<SUP>&reg;</SUP> EQUAL WEIGHT
INDEX OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL S&amp;P DOW JONES INDICES HAVE ANY LIABILITY
FOR ANY LOST PROFITS OR INDIRECT, PUNITIVE, SPECIAL OR CONSEQUENTIAL DAMAGES, EVEN IF NOTIFIED OF THE POSSIBILITY THEREOF. THERE ARE NO
THIRD PARTY BENEFICIARIES OF ANY AGREEMENTS OR ARRANGEMENTS BETWEEN S&amp;P DOW JONES INDICES AND CITIGROUP INC.</B>&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp238184_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-12-01</xbrli:startDate>
          <xbrli:endDate>2025-12-01</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-12-01</xbrli:startDate>
          <xbrli:endDate>2025-12-01</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-12-01</xbrli:startDate>
          <xbrli:endDate>2025-12-01</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">2,615</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">2,615,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">361.13</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">2,615,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">361.13</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">361.13</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">2,615,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %  D$# 2(  A$! Q$!_\0
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M'_/[;_\ ?U?\:/[3L/\ G]M_^_J_XUG^>W_/O-_X[_C1Y[?\^\W_ ([_ (T
M:']IV'_/[;_]_5_QH_M.P_Y_;?\ [^K_ (UG^>W_ #[S?^._XT>>W_/O-_X[
M_C0!H?VG8?\ /[;_ /?U?\:/[3L/^?VW_P"_J_XUG^>W_/O-_P"._P"-'GM_
MS[S?^._XT :']IV'_/[;_P#?U?\ &C^T[#_G]M_^_J_XUG^>W_/O-_X[_C1Y
M[?\ /O-_X[_C0!H?VG8?\_MO_P!_5_QH_M.P_P"?VW_[^K_C6?Y[?\^\W_CO
M^-'GM_S[S?\ CO\ C0!H?VG8?\_MO_W]7_&C^T[#_G]M_P#OZO\ C6?Y[?\
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MC^T[#_G]M_\ OZO^-9_GM_S[S?\ CO\ C1Y[?\^\W_CO^- &A_:=A_S^V_\
MW]7_ !H_M.P_Y_;?_OZO^-9_GM_S[S?^._XT>>W_ #[S?^._XT :']IV'_/[
M;_\ ?U?\:/[3L/\ G]M_^_J_XUG^>W_/O-_X[_C1Y[?\^\W_ ([_ (T :']I
MV'_/[;_]_5_QH_M.P_Y_;?\ [^K_ (UG^>W_ #[S?^._XT>>W_/O-_X[_C0!
MH?VG8?\ /[;_ /?U?\:/[3L/^?VW_P"_J_XUG^>W_/O-_P"._P"-'GM_S[S?
M^._XT :']IV'_/[;_P#?U?\ &C^T[#_G]M_^_J_XUG^>W_/O-_X[_C1Y[?\
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M !H_M.P_Y_;?_OZO^-9_GM_S[S?^._XT>>W_ #[S?^._XT :']IV'_/[;_\
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MH/RHP/0?E0!']I@_Y[Q?]]BC[3!_SWB_[[%28'H/RHP/0?E0!']I@_Y[Q?\
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MY_YZ1?\ ?L_XT8N?^>D7_?L_XT +]G7^_-_W];_&C[.O]^;_ +^M_C28N?\
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MO_CO^-'G/_S[R_\ CO\ C4GF)_?7\Z/,3^^OYT 1^<__ #[R_P#CO^-'G/\
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M]?SH\Q/[Z_G0!'YS_P#/O+_X[_C1YS_\^\O_ ([_ (U)YB?WU_.CS$_OK^=
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ML659?NC)[G/L:X#) (SQ7G8G%.$[0.#$8APE:)Z'X<UFZU.UGDN(M[))@>4
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MY$/_ #RC_P"^13?(/_/>;_OH?X4>0?\ GO-_WT/\* '>1#_SRC_[Y%'D0_\
M/*/_ +Y%-\@_\]YO^^A_A1Y!_P">\W_?0_PH =Y$/_/*/_OD4>1#_P \H_\
MOD4WR#_SWF_[Z'^%'D'_ )[S?]]#_"@!WD0_\\H_^^11Y$/_ #RC_P"^13?(
M/_/>;_OH?X4>0?\ GO-_WT/\* '>1#_SRC_[Y%'D0_\ /*/_ +Y%-\@_\]YO
M^^A_A1Y!_P">\W_?0_PH =Y$/_/*/_OD4>1#_P \H_\ OD4WR#_SWF_[Z'^%
M'D'_ )[S?]]#_"@!WD0_\\H_^^11Y$/_ #RC_P"^13?(/_/>;_OH?X4>0?\
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MTA_,T?Z3Z0_F:7S_ /IC-_WQ1Y__ $QF_P"^* $_TGTA_,T?Z3Z0_F:7S_\
MIC-_WQ1Y_P#TQF_[XH 3_2?2'\S1_I/I#^9I?/\ ^F,W_?%'G_\ 3&;_ +XH
M 3_2?2'\S1_I/I#^9I?/_P"F,W_?%'G_ /3&;_OB@!/])](?S-'^D^D/YFE\
M_P#Z8S?]\4>?_P!,9O\ OB@!/])](?S-'^D^D/YFE\__ *8S?]\4>?\ ],9O
M^^* $_TGTA_,T?Z3Z0_F:7S_ /IC-_WQ1Y__ $QF_P"^* $_TGTA_,T?Z3Z0
M_F:7S_\ IC-_WQ1Y_P#TQF_[XH 3_2?2'\S1_I/I#^9I?/\ ^F,W_?%'G_\
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MV&F^<UM]I7:$+?9MZX7Y-N[U^[[XJ*]CMSX:U.2*Y%WYD,C/*2K;B%Q_",<
M"@"4RQY/[Q/^^A2>;'_ST3_OH4IBBR?W:?\ ?(I/*B_YYI_WR* #S8_^>B?]
M]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_
M 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_
MWR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_W
MR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]
M]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_
M 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_
MWR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_W
MR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]
M]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_
M 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_
MWR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_W
MR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]
M]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_
M 'T*/*B_YYI_WR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_
MWR*/*B_YYI_WR* #S8_^>B?]]"CS8_\ GHG_ 'T*/*B_YYI_WR*/*B_YYI_W
MR* #S8_^>B?]]"CS8_\ GHG_ 'T*Q/$.M1:,D<<5M')<2?, R_*%]:I6'BA;
M_5X+1+&(12X&XC# XR?J*PEB*<9<C>IBZ\%+E;U.H\V/_GHG_?0H\V/_ )Z)
M_P!]"CRHO^>:?]\BCRHO^>:?]\BMS8/-C_YZ)_WT*/-C_P">B?\ ?0H\J+_G
MFG_?(H\J+_GFG_?(H /-C_YZ)_WT*/-C_P">B?\ ?0H\J+_GFG_?(H\J+_GF
MG_?(H /-C_YZ)_WT*/-C_P">B?\ ?0H\J+_GFG_?(H\J+_GFG_?(H /-C_YZ
M)_WT*/-C_P">B?\ ?0H\J+_GFG_?(H\J+_GFG_?(H /-C_YZ)_WT*YSQEJ#0
MZ;'!#(O[YB'*MR .<?C70R1QI&["&,E5) *CFO-=$MFU+7H%+8)?S6)&>!S_
M /6KCQ51I*G'>1RXF;24%NSI/#F@6L5NMS>&VF,JH\8/5./?ZU1\(PF+7+IP
M/W,:M'N+ 8.>/Y5VWE1?\\D_[Y%106%I;!A!;1('.YL*.35+#13CR]!K#I.-
MN@]S!*C)(T3HPP58@@T1_9X8Q'$8D1>BJ0 /PIWE1?\ /-/^^11Y47_/-/\
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M?F7\E_PHW7'_ #RB_P"_A_\ B:-UQ_SRB_[^'_XF@ \E_P#GYE_)?\*/)?\
MY^9?R7_"C=<?\\HO^_A_^)HW7'_/*+_OX?\ XF@ \E_^?F7\E_PH\E_^?F7\
ME_PHW7'_ #RB_P"_A_\ B:-UQ_SRB_[^'_XF@ \E_P#GYE_)?\*/)?\ Y^9?
MR7_"C=<?\\HO^_A_^)HW7'_/*+_OX?\ XF@ \E_^?F7\E_PH\E_^?F7\E_PH
MW7'_ #RB_P"_A_\ B:-UQ_SRB_[^'_XF@ \E_P#GYE_)?\*/)?\ Y^9?R7_"
MC=<?\\HO^_A_^)HW7'_/*+_OX?\ XF@ \E_^?F7\E_PH\E_^?F7\E_PHW7'_
M #RB_P"_A_\ B:-UQ_SRB_[^'_XF@ \E_P#GYE_)?\*/)?\ Y^9?R7_"C=<?
M\\HO^_A_^)HW7'_/*+_OX?\ XF@ \E_^?F7\E_PH\E_^?F7\E_PHW7'_ #RB
M_P"_A_\ B:-UQ_SRB_[^'_XF@ \E_P#GYE_)?\*/)?\ Y^9?R7_"C=<?\\HO
M^_A_^)HW7'_/*+_OX?\ XF@ \E_^?F7\E_PH\E_^?F7\E_PHW7'_ #RB_P"_
MA_\ B:-UQ_SRB_[^'_XF@ \E_P#GYE_)?\*/)?\ Y^9?R7_"C=<?\\HO^_A_
M^)HW7'_/*+_OX?\ XF@ \E_^?F7\E_PH\E_^?F7\E_PHW7'_ #RB_P"_A_\
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MX_YY1?\ ?P__ !-=IV!Y+_\ /S+^2_X4>2__ #\R_DO^%&ZX_P">47_?P_\
MQ-&ZX_YY1?\ ?P__ !- !Y+_ //S+^2_X4>2_P#S\R_DO^%&ZX_YY1?]_#_\
M31NN/^>47_?P_P#Q- !Y+_\ /S+^2_X4>2__ #\R_DO^%&ZX_P">47_?P_\
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M=SQV\A"3;9<J$W'8IW'<1QMP,GTIER++[) !:23I*BF*!<#"JO8$C'!Q^.*
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M^[+_ -^F_P */M*?W9?^_3?X5+10!%]I3^[+_P!^F_PH^TI_=E_[]-_A4M%
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M_A1Y+_\ /Q+_ .._X4 'V6W_ .>$7_? H^RV_P#SPB_[X%'DO_S\2_\ CO\
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M 'V6W_YX1?\ ? H^RV__ #PB_P"^!1Y+_P#/Q+_X[_A1Y+_\_$O_ ([_ (4
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M?_'?\*/)?_GXE_\ '?\ "NDZ ^RV_P#SPB_[X%'V6W_YX1?]\"CR7_Y^)?\
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M%>@=P?9;?_GA%_WP*/LMO_SPB_[X%'DO_P _$O\ X[_A1Y+_ //Q+_X[_A0
M?9;?_GA%_P!\"C[+;_\ /"+_ +X%'DO_ ,_$O_CO^%'DO_S\2_\ CO\ A0 ?
M9;?_ )X1?]\"C[+;_P#/"+_O@4>2_P#S\2_^._X4>2__ #\2_P#CO^% !]EM
M_P#GA%_WP*/LMO\ \\(O^^!1Y+_\_$O_ ([_ (4>2_\ S\2_^._X4 'V6W_Y
MX1?]\"C[+;_\\(O^^!1Y+_\ /Q+_ .._X4>2_P#S\2_^._X4 'V6W_YX1?\
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M_P"%'VJ'^\?^^3_A0 ;KG_GG%_W\/_Q-&ZY_YYQ?]_#_ /$T?:H?[Q_[Y/\
MA1]JA_O'_OD_X4 &ZY_YYQ?]_#_\31NN?^><7_?P_P#Q-'VJ'^\?^^3_ (4?
M:H?[Q_[Y/^% !NN?^><7_?P__$T;KG_GG%_W\/\ \31]JA_O'_OD_P"%'VJ'
M^\?^^3_A0 ;KG_GG%_W\/_Q-&ZY_YYQ?]_#_ /$T?:H?[Q_[Y/\ A1]JA_O'
M_OD_X4 &ZY_YYQ?]_#_\31NN?^><7_?P_P#Q-'VJ'^\?^^3_ (4?:H?[Q_[Y
M/^% !NN?^><7_?P__$T;KG_GG%_W\/\ \31]JA_O'_OD_P"%'VJ'^\?^^3_A
M0 ;KG_GG%_W\/_Q-&ZY_YYQ?]_#_ /$T?:H?[Q_[Y/\ A1]JA_O'_OD_X4 &
MZY_YYQ?]_#_\31NN?^><7_?P_P#Q-'VJ'^\?^^3_ (4?:H?[Q_[Y/^% !NN?
M^><7_?P__$T;KG_GG%_W\/\ \31]JA_O'_OD_P"%'VJ'^\?^^3_A0 ;KG_GG
M%_W\/_Q-&ZY_YYQ?]_#_ /$T?:H?[Q_[Y/\ A1]JA_O'_OD_X4 &ZY_YYQ?]
M_#_\31NN?^><7_?P_P#Q-'VJ'^\?^^3_ (4?:H?[Q_[Y/^% !NN?^><7_?P_
M_$T;KG_GG%_W\/\ \31]JA_O'_OD_P"%'VJ'^\?^^3_A0 ;KG_GG%_W\/_Q-
M&ZY_YYQ?]_#_ /$T?:H?[Q_[Y/\ A1]JA_O'_OD_X4 &ZY_YYQ?]_#_\31NN
M?^><7_?P_P#Q-'VJ'^\?^^#_ (4?:H?[Y_[Y/^% &7KFM/I%LI>&-GER$ <_
MCGBN%33KFYTR;45#.L<@5B22<>OOVK5N[^'Q)XAMH95>*V7<@*G+'J<_F*[&
MP2STZRCM8&;8@ZE3DGN3Q7G.'UF;=_=6B]3@<?K$V[^ZCE]%\.7<5QI^HH8B
MFT2,K,01G..WH178;KG_ )YQ?]_#_P#$T?:H?[Q_[Y/^%'VJ'^\?^^3_ (5V
M4J4:2M$ZZ=*--60;KG_GG%_W\/\ \31NN?\ GG%_W\/_ ,31]JA_O'_OD_X4
M?:H?[Q_[Y/\ A6IH&ZY_YYQ?]_#_ /$T;KG_ )YQ?]_#_P#$T?:H?[Q_[Y/^
M%'VJ'^\?^^3_ (4 &ZY_YYQ?]_#_ /$T;KG_ )YQ?]_#_P#$T?:H?[Q_[Y/^
M%'VJ'^\?^^3_ (4 &ZY_YYQ?]_#_ /$T;KG_ )YQ?]_#_P#$T?:H?[Q_[Y/^
M%'VJ'^\?^^3_ (4 8^BZ%+I$MQ(1;RM(V48DAD7TSBI=?L[B_P!&GB\I"Z_.
M@1R3D?A6G]JA_O'_ +Y/^%'VJ'^\?^^3_A67LHJ'(MC/V<5#D6QYAI""76+.
M,HCAI5!5QP?K5HZ1(/$HTQSC,O&#QMQGC\/:N]2+38I1+';PI(.0RPX/YXIP
M6P%VUT(U^T,-ID\L[B/RKCC@K))OK^!R1PEDDWU)@;@ #RXN/^FA_P#B:-US
M_P \XO\ OX?_ (FC[5#_ 'C_ -\G_"C[5#_>/_?)_P *]$[PW7/_ #SB_P"_
MA_\ B:-US_SSB_[^'_XFC[5#_>/_ 'R?\*/M4/\ >/\ WR?\* #=<_\ /.+_
M +^'_P")HW7/_/.+_OX?_B:/M4/]X_\ ?)_PH^U0_P!X_P#?)_PH -US_P \
MXO\ OX?_ (FC=<_\\XO^_A_^)H^U0_WC_P!\G_"C[5#_ 'C_ -\G_"@ W7/_
M #SB_P"_A_\ B:-US_SSB_[^'_XFC[5#_>/_ 'R?\*/M4/\ >/\ WR?\* #=
M<_\ /.+_ +^'_P")HW7/_/.+_OX?_B:/M4/]X_\ ?)_PH^U0_P!X_P#?)_PH
M -US_P \XO\ OX?_ (FC=<_\\XO^_A_^)H^U0_WC_P!\G_"C[5#_ 'C_ -\G
M_"@ W7/_ #SB_P"_A_\ B:-US_SSB_[^'_XFC[5#_>/_ 'R?\*/M4/\ >/\
MWR?\* (YC/B/<D87SH\D.2?OK[5OU@37$3B-58DF:/\ A/\ ?7VK?H ****
M"BBB@"A?1VD:'S(9'>>4$+$Q#LX7&001CY5]1P*KW L3:0MLFFB=1Y44+$$
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M9+?_ )Y+0!/S[T<^]0?9+?\ YY+1]DM_^>2T 3\^]'/O4'V2W_YY+1]DM_\
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M?/\ \\%_[^?_ %J-\_\ SP7_ +^?_6H /*E_Y^6_[X7_  H\J7_GY;_OA?\
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M^?\ UJ #RI?^?EO^^%_PH\J7_GY;_OA?\*-\_P#SP7_OY_\ 6HWS_P#/!?\
MOY_]:@ \J7_GY;_OA?\ "CRI?^?EO^^%_P *-\__ #P7_OY_]:C?/_SP7_OY
M_P#6H /*E_Y^6_[X7_"CRI?^?EO^^%_PHWS_ //!?^_G_P!:C?/_ ,\%_P"_
MG_UJ #RI?^?EO^^%_P */*E_Y^6_[X7_  HWS_\ /!?^_G_UJ-\__/!?^_G_
M -:@ \J7_GY;_OA?\*/*E_Y^6_[X7_"C?/\ \\%_[^?_ %J-\_\ SP7_ +^?
M_6H /*E_Y^6_[X7_  H\J7_GY;_OA?\ "C?/_P \%_[^?_6HWS_\\%_[^?\
MUJ #RI?^?EO^^%_PH\J7_GY;_OA?\*-\_P#SP7_OY_\ 6HWS_P#/!?\ OY_]
M:@ \J7_GY;_OA?\ "CRI?^?EO^^%_P *-\__ #P7_OY_]:C?/_SP7_OY_P#6
MH /*E_Y^6_[X7_"CRI?^?EO^^%_PHWS_ //!?^_G_P!:C?/_ ,\%_P"_G_UJ
M #RI?^?EO^^%_P */*E_Y^6_[X7_  HWS_\ /!?^_G_UJ-\__/!?^_G_ -:@
M \J7_GY;_OA?\*/*E_Y^6_[X7_"C?/\ \\%_[^?_ %J-\_\ SP7_ +^?_6H
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MLGEO^_;?X4GVJ+U;_OVW^%3GJ:2@"'[5%ZM_W[;_  H^U1>K?]^V_P *FHH
MA^U1>K?]^V_PH^U1>K?]^V_PJ:B@"'[5%ZM_W[;_  H^U1>K?]^V_P *FHH
MA^U1>K?]^V_PH^U1>K?]^V_PJ:B@"'[5%ZM_W[;_  H^U1>K?]^V_P *FYJ.
M>XAMHC+/*D:#JSG H;MN&PW[5%ZM_P!^V_PH^U1>K?\ ?#?X5ST_C 27'DZ;
M9271ZYY&1[ #-4)I?$'B">.U:![.$@EB%95(]SW^E<TL3#:.K\O\SG>(CM'5
MG3'7-+ 8F^A^7[W/2JTGBK1TB#BZ+Y.-JH<_E6-)X%;R4\J^'F_Q[D^7\*UX
MO">DH8V:W9V0#.7.&..XJ5+$2^RD3S5WT2,B_P#%L]Y-';:1&R,[;=\BC)^@
M[57AT'4+VX5M4NW,2N"5)=RP[XXXKL;/3[6PB,=K L:D[B!SS^-6:%AW/6J[
M_D"H.6M1W_(Y"W\/0C4=0,B[;:5&6W(0DIGOC':FV'A2V@N5FNKMI0C!E1(6
M ./7BNQHJUAJ78OZO3[$/VJ(]W_[]M_A1]JB]6_[]M_A4U%=!N9NH6FG:G&5
MN8RS;2JN(VW+GT.*X?4-)CM]=CL+=IGADV')4[L=SC'..:]*J)[6"2Y2X>%&
MF0860CE1[&N:MAXU/4YZU"-3U*MC#8Z;;"WME=4!R<HQ)/J>*L_:HO5O^_;?
MX5-170DDK(W225D0_:HO5O\ OVW^%'VJ+U;_ +]M_A4U%,9#]JB]6_[]M_A1
M]JB]6_[]M_A4U% $/VJ+U;_OVW^%'VJ+U;_OVW^%344 0_:HO5O^_;?X4?:H
MO5O^_;?X5-10!#]JB]6_[]M_A1]JB]6_[]M_A4U% $/VJ+U;_OVW^%'VJ+U;
M_OVW^%344 0_:HO5O^_;?X4?:HO5O^_;?X5-10!#]JB]6_[]M_A1]JB]6_[]
MM_A4U% $/VJ+U;_OVW^%'VJ+U;_OVW^%344 0_:HO5O^_;?X4?:HO5O^_;?X
M5-10!#]JB]6_[]M_A1]JB]6_[]M_A4U% $/VJ+U;_OVW^%'VJ+U;_OVW^%34
M4 0_:HO5O^_;?X4?:HO5O^_;?X5-10!#]JB]6_[]M_A1]JB]6_[]M_A4U% $
M/VJ+U;_OVW^%'VJ+U;_OVW^%344 0_:HO5O^_;?X4?:HO5O^_;?X5-10!#]J
MB]6_[]M_A1]JB]6_[]M_A4U% $/VJ+U;_OVW^%'VJ+U;_OVW^%344 0_:HO5
MO^_;?X4?:HO5O^_;?X5-10!5FN(W$:@MDS1]4(_C7VK?K%N/N)_UUC_]#6MJ
M@ HHHH **** *M]:_:H54) Y1MP$\>]>A'X=>M5&LIHXK?RYXPUNFQ)9>0VX
M8.1GV&*GU2&ZN+<16XB9&SYJNY7<N.@(![]?:L[[/+_9VG03V9F-O JS0 !A
MN*8&,X!P01^- $AT-3']C$Z?9P"P7'SAC'Y>>O3&32:C;%?#VK2S2H[S1.[-
M%E5&$P,<_P"S54Z7>&/R?+)N@I)NN,,OD[-N<Y^]C\JDO;9AX<UO9#]ECFB<
MI$R@;1Y8!X!P,D&A@9>H^(=(LB!&\ERY[0RD@?4YJG/XNTQ%0PV]S)D_,&D*
M[1^9S5JS\'6EI(7:;SR5*[9(_EYZ\ U?M]#M+63S(8+97Z9\G./S-<B6(EJV
ME^)RI5Y=4CG6\8P8.VQD!YP3<,?I3K+Q3F>--0M#%$_/FK)(,#UP3S74O8B1
M=KK;,I[&W!'\ZS=7\.G5?LP-RD20 J D.....OM4RAB%JI7\K"E"NM5*YD:K
MXGB*Q1Z3YC.Q^9GW\>@ SUJG+KNM0!99K9DB;D;D< C/KFNETSPW#I4SRQ2B
M1VQM,L0)3Z<U=O\ 3SJ-F]M<2J8W](\$'L1S2]E7DG)RL^RV%[.M)-N5GV*1
MUK15M%N&N\;E!*+*S,"1G& :RE\7V1N=K6<ZP;L>9YS9 ]<?TS38_!##4#YE
MP#9CE3_&>G!'Y]ZZ%]'MWMDMWBMFB3[JF#I^M4OK$^T;?B->WEV7ZF!+XOL/
M)D\FUN/- ^3?*=I/O@U#%8>);ZV:\6ZDAW\I#YI4D'T]/QK=F\-V<Q@^2*/R
M6W*(X]N>_//-:>R?_GLG_?K_ .O35&I)_O)?=H-4JDG^\E]VAQ\WAS75MHIU
MO9);@-DQB4C9[[B>:=#X1O[R4R:I>'C&"',C'\^E=?LN/^>R?]^__KT;+C_G
MLG_?O_Z]'U2G?6_WC^JPZW^\JV6BV&GIMMH2A(PS;SN;ZG-6OLT7^W_W\;_&
MC9<?\]D_[]__ %Z-EQ_SV3_OW_\ 7KJ2459'0DDK(3[-%_M_]_&_QH^S1?[?
M_?QO\:79<?\ /9/^_?\ ]>C9<?\ /9/^_?\ ]>F,3[-%_M_]_&_QH^S1?[?_
M '\;_&EV7'_/9/\ OW_]>C9<?\]D_P"_?_UZ $^S1?[?_?QO\:/LT7^W_P!_
M&_QI=EQ_SV3_ +]__7HV7'_/9/\ OW_]>@!/LT7^W_W\;_&C[-%_M_\ ?QO\
M:79<?\]D_P"_?_UZ-EQ_SV3_ +]__7H 3[-%_M_]_&_QH^S1?[?_ '\;_&EV
M7'_/9/\ OW_]>C9<?\]D_P"_?_UZ $^S1?[?_?QO\:/LT7^W_P!_&_QI=EQ_
MSV3_ +]__7HV7'_/9/\ OW_]>@!/LT7^W_W\;_&C[-%_M_\ ?QO\:79<?\]D
M_P"_?_UZ-EQ_SV3_ +]__7H 3[-%_M_]_&_QH^S1?[?_ '\;_&EV7'_/9/\
MOW_]>C9<?\]D_P"_?_UZ $^S1?[?_?QO\:/LT7^W_P!_&_QI=EQ_SV3_ +]_
M_7HV7'_/9/\ OW_]>@!/LT7^W_W\;_&C[-%_M_\ ?QO\:79<?\]D_P"_?_UZ
M-EQ_SV3_ +]__7H 3[-%_M_]_&_QH^S1?[?_ '\;_&EV7'_/9/\ OW_]>C9<
M?\]D_P"_?_UZ $^S1?[?_?QO\:/LT7^W_P!_&_QI=EQ_SV3_ +]__7HV7'_/
M9/\ OW_]>@!/LT7^W_W\;_&C[-%_M_\ ?QO\:79<?\]D_P"_?_UZ-EQ_SV3_
M +]__7H 3[-%_M_]_&_QH^S1?[?_ '\;_&EV7'_/9/\ OW_]>C9<?\]D_P"_
M?_UZ $^S1?[?_?QO\:/LT7^W_P!_&_QI=EQ_SV3_ +]__7HV7'_/9/\ OW_]
M>@!/LT7^W_W\;_&C[-%_M_\ ?QO\:79<?\]D_P"_?_UZ-EQ_SV3_ +]__7H
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M_P!_&_QI=EQ_SV3_ +]__7HV7'_/9/\ OW_]>@!/LT7^W_W\;_&C[-%_M_\
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M9/SH /-E_P"?9_\ OI?\:/-E_P"?9_\ OI?\:/M=O_SV3\Z/M=O_ ,]D_.@
M\V7_ )]G_P"^E_QH\V7_ )]G_P"^E_QH^UV__/9/SH^UV_\ SV3\Z #S9?\
MGV?_ +Z7_&CS9?\ GV?_ +Z7_&C[7;_\]D_.C[7;_P#/9/SH /-E_P"?9_\
MOI?\:/-E_P"?9_\ OI?\:/M=O_SV3\Z/M=O_ ,]D_.@ \V7_ )]G_P"^E_QH
M\V7_ )]G_P"^E_QH^UV__/9/SH^UV_\ SV3\Z #S9?\ GV?_ +Z7_&CS9?\
MGV?_ +Z7_&C[7;_\]D_.C[7;_P#/9/SH /-E_P"?9_\ OI?\:/-E_P"?9_\
MOI?\:/M=O_SV3\Z/M=O_ ,]D_.@ \V7_ )]G_P"^E_QH\V7_ )]G_P"^E_QH
M^UV__/9/SH^UV_\ SV3\Z #S9?\ GV?_ +Z7_&CS9?\ GV?_ +Z7_&C[7;_\
M]D_.C[7;_P#/9/SH /-E_P"?9_\ OI?\:/-E_P"?9_\ OI?\:/M=O_SV3\Z/
MM=O_ ,]D_.@ \V7_ )]G_P"^E_QH\V7_ )]G_P"^E_QH^UV__/9/SH^UV_\
MSV3\Z #S9?\ GV?_ +Z7_&CS9?\ GV?_ +Z7_&C[7;_\]D_.C[7;_P#/9/SH
M /-E_P"?9_\ OI?\:/-E_P"?9_\ OI?\:/M=O_SV3\Z/M=O_ ,]D_.@ \V7_
M )]G_P"^E_QH\V7_ )]G_P"^E_QH^UV__/9/SH^UV_\ SV3\Z #S9?\ GV?_
M +Z7_&CS9?\ GV?_ +Z7_&C[7;_\]D_.C[7;_P#/9/SH /-E_P"?9_\ OI?\
M:/-E_P"?9_\ OI?\:/M=O_SV3\Z/M=O_ ,]D_.@ \V7_ )]G_P"^E_QH\V7_
M )]G_P"^E_QH^UV__/9/SH^UV_\ SV3\Z #S9?\ GV?_ +Z7_&CS9?\ GV?_
M +Z7_&C[7;_\]D_.C[7;_P#/9/SH /-E_P"?9_\ OI?\:/-E_P"?9_\ OI?\
M:/M=O_SV3\Z/M=O_ ,]D_.@ \V7_ )]G_P"^E_QH\V7_ )]G_P"^E_QH^UV_
M_/9/SH^UV_\ SV3\Z #S9?\ GV?_ +Z7_&CS9?\ GV?_ +Z7_&C[7;_\]D_.
MC[7;_P#/9/SH /-E_P"?9_\ OI?\:/-E_P"?9_\ OI?\:/M=O_SV3\Z/M=O_
M ,]D_.@ \V7_ )]G_P"^E_QH\V7_ )]G_P"^E_QH^UV__/9/SH^UV_\ SV3\
MZ #S9?\ GV?_ +Z7_&CS9?\ GV?_ +Z7_&C[7;_\]D_.C[7;_P#/9/SH /-E
M_P"?9_\ OI?\:/-E_P"?9_\ OI?\:/M=O_SV3\Z/M=O_ ,]D_.@ \V7_ )]G
M_P"^E_QH\V7_ )]G_P"^E_QH^UV__/9/SH^UV_\ SV3\Z #S9?\ GV?_ +Z7
M_&CS9?\ GV?_ +Z7_&C[7;_\]D_.C[7;_P#/9/SH /-E_P"?9_\ OI?\:/-E
M_P"?9_\ OI?\:/M=O_SV3\Z/M=O_ ,]D_.@".:20B,&!E'G1\EEX^=?>M^L"
M:YA<1JLJDF:/ !_VUK?H **** "BBB@"CJWV46#R7LLD4$9WDHY4G';CD_2H
M;Z.VCAC\][F0$ 1B,L7X!R<CGD=:O7EO]JLI[?=M\V-DW8SC(QFJUS:7$LD;
MPO'&\*X1G4L"",-D9'H,4 5"^D>>Q(?RS&>?F\K[G..V[9^E-NC;_P#"-ZH(
M!,&$,GF"?=OW;.^[GIBG'0!Y/V7SA]E )5=IW!C'Y?7/3&3TI-2LWCT#5GN'
M5Y9HG=C&"HX3 QR?2@"<YR:.:A-M%D\-_P!]M_C2?9HO1O\ OMO\: )^:.:@
M^S1>C?\ ?;?XT?9HO1O^^V_QH GYHYJ#[-%Z-_WVW^-'V:+T;_OMO\: )^:.
M:@^S1>C?]]M_C1]FB]&_[[;_ !H GYHYJ#[-%Z-_WVW^-'V:+T;_ +[;_&@"
M?FCFH/LT7HW_ 'VW^-'V:+T;_OMO\: )^:.:@^S1>C?]]M_C1]FB]&_[[;_&
M@"?FCFH/LT7HW_?;?XT?9HO1O^^V_P : )^:.:@^S1>C?]]M_C1]FB]&_P"^
MV_QH GYHYJ#[-%Z-_P!]M_C1]FB]&_[[;_&@"?FCFH/LT7HW_?;?XT?9HO1O
M^^V_QH GYHYJ#[-%Z-_WVW^-'V:+T;_OMO\ &@"?FCFH/LT7HW_?;?XT?9HO
M1O\ OMO\: )^:.:@^S1>C?\ ?;?XT?9HO1O^^V_QH GYHYJ#[-%Z-_WVW^-'
MV:+T;_OMO\: )^:.:@^S1>C?]]M_C1]FB]&_[[;_ !H GYHYJ#[-%Z-_WVW^
M-'V:+T;_ +[;_&@"?FCFH/LT7HW_ 'VW^-'V:+T;_OMO\: )^:.:@^S1>C?]
M]M_C1]FB]&_[[;_&@"?FCFH/LT7HW_?;?XT?9HO1O^^V_P : )^:.:@^S1>C
M?]]M_C1]FB]&_P"^V_QH GYHYJ#[-%Z-_P!]M_C1]FB]&_[[;_&@"?FCFH/L
MT7HW_?;?XT?9HO1O^^V_QH GYHYJ#[-%Z-_WVW^-'V:+T;_OMO\ &@"?FCFH
M/LT7HW_?;?XT?9HO1O\ OMO\: )^:.:@^S1>C?\ ?;?XT?9HO1O^^V_QH GY
MHYJ#[-%Z-_WVW^-'V:+T;_OMO\: )^:.:@^S1>C?]]M_C1]FB]&_[[;_ !H
MGYHYJ#[-%Z-_WVW^-'V:+T;_ +[;_&@"?FCFH/LT7HW_ 'VW^-'V:+T;_OMO
M\: )^:.:@^S1>C?]]M_C1]FB]&_[[;_&@"?FCFH/LT7HW_?;?XT?9HO1O^^V
M_P : %N,[$_ZZQ_^AK6U6!-;QH(V ;(FC_C)_C7WK?H **** "BBB@ HHHH
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MB8@RLAN9)7C9^N Q(&3G)'7FK=Y]OAOV>UM;+R)(LRSRN0<KV8 =,'@_7IW
M*LYGM[+[8^H6;6^5 >.V=\DL%&-KG/) IMJ\UX[)#JFFR."?D2-BP'N-^0:T
MIHK@Z056VM)+E0'2+)$18'*\XXY .<=:;9-?R7 >\ALT/E@D1L3(N>@/'3KW
M[4 9<UT\-U);2:G81RQLJOYL#HHR <!BV"<'.,U//]HM[(WDE_9FW !WI;N^
M<G QASGD]JL77]H0WTQMK6Q%M(@>2>5R"6'!# #TQ@^@[=[4T,SZ4T?V>VDG
M"96(DB(L.0,XR!D#M0!E6LDUVYCBU337DR?W:QMN ]QOR#[5'<W,]M/Y!O+=
MY P4JEG*YSC=@;6.6Q@X].:T[)M0EG1[R"RC/E@LJ,6D3/;ICKGOVJCJ-A=3
M:G+(MI:K"%5UN&N9(VW8VG.W&&Q@9'4<9[4 .(N!9+>?;[,V[A2KBW<[MV ,
M#?DDD@8]ZAM+B>\G,,=[;;SNV[K.50P4X."6 )!X('0UJ7%K(NAFW@M;=Y4C
M 2 L5CW#! !QD<C@]N*J:3I\MO=^;+;VT9"'Y4G=V0M@GAN!G')'4CO0!4N+
MN6WN/)-[;NX;:RQV4KGID@;6.2.,CL#5AQ<1V:79O[,P.%*,MN[;]WW< /DD
MY&,5'?:==3:E.XL[1(?E,<YN9(RQ/!X7&#T!]1CD]!HWUM*-%,-M:022QHOE
MP[RB@KCA6'*D8X/'..E &993SWTIBBO;4OAF7-I( Z@X)!+#.,@''0FH[V]E
ML91')=1.?,$;&*PFD"L1D E6(SR.#ZCU%7](T][6Y=WAM4PFT"*9W*9()&&X
M4'J<=3@U!>V%TVK33):6@@(5Q+)<R*&?&,L@XW# PV,].>* %?[0EI'=?;[-
MH90#&4MG8OGD;0'R<^U0:==3:FSI#>6ZRH6W))92QGAB.C,">>OI6CJ-G*=#
M2"WLH)98@A2$2&-5(_N,.01VZ?44:5926TTADAM%*C;NBD=WR3N.XMSSD$]S
MWH R[R_DLIECDNX6S)Y;-'83.JM@G&5)&?:KDBW,5JMRU_9F)\;&6W=M^>FW
M#\Y[8J*ZT^Z;4[F1;.S6$LK)))<R!79AM)*#@/VSC/(YK0U*UD;1##;VD$LL
M:J8X=YC4%<?=8<J1CCIVZ4 9>GW4VI2R117D"S1E@4DLI8S@'!X9AGJ,XZ9'
MJ*26\FCD<?:HFCC9EEE2PF9$*]?F#8X/7GBM'2K*2WG=I8;1652NZ.1WDR2"
M=Q;UX).<G ]!6;=:?=*NH730AAOD"6:.Z)+G[IX<*Q;(R".22/<@%JX%S:P)
M-)?6A20A4V6KN7)Y 4!\G\*CLWN[QS$+JWCF W&.2SE1MN<9 9@2*MZC;W-U
MI-I&L*+(7CWD*<P\<L@!!R#QP> 3UZ5'IEO/:ZN\+0B1%@PUV9&<LV[A<LQ*
M\'.WIR#0!2>^E1W/VN$PQ[A).+"8QJ5.#\P;;@8.3GC%6KI;JR1'FO+;]XVQ
M%2TD=F."< !R3P"?PJC=Z?>1VE_<_9UD<M,([ .ZHY.2IV[]K[N"00,DGTK8
MUBVGN[>UCB4 ^<-\H!+0C:1N7!!!R0,YX!- %*S-Y>%D6ZMTF50SQR6DB, 2
M0#AF!QP>?:H9;Y(9VB?7-'5D8K(K AD([8W]:NZ3!-;ZG<Q/"#&L*#[5YC.9
M&W/E<LQ88&/E/3=WS4<K:I:IJ-['% TQ9U2 1A3)@$1D-GYB1C@X].,4 %UY
MUC&DEWJFG0([;5:6,J&.,X&7Y. :2R^T7\9:VU/39BN-_DQLX4_4/5O4([RY
M@LHT2,;G5IG:/?Y9 R"%S_> Y[5)8W-[+?7,5Q$@AB1 DJ?=D?+[\<Y&,+P>
MASUH R&OD2<Q'7-'#*Q1P0=RL#C&-_7K5JZ6>QC62\U/3K>-F"AI8BH)]!E^
MO!J.235K.SU"[B@@>Y=I-ELL84LP!"$-GYR0%ST[],8K1U:*YGB@A@6,J\R^
M:[Q[]@&2"%R/X@O/;K0!GV1GOT)MM3TV9DQO$,;.%)^CU UY(KRYO[41P[_,
MD:SE"Y3.X*=V&(P<@'M6M97%])J%Q#<1IY$4:;9H^CN2^[OD8 7@],]365?6
MU[_9.JJ]K!-'*TRK8E,!\YVE6W<EN"1QR3T/4 FNFN;183)>6Y,QQ&L=G([-
MQGHK$XQ2VHNKMBD5_9-(J*[A;=R &R!SO]5;\JM7\%U*=/$"I&5;YY=FXQ?+
MV&1P3P?\D-TN.4:OJ,LEI%'O6(&>/I,PW@]^,<#'4'/7K0!G?;GQ,YU"U6&)
M7)D:TE ;;G=M.[#8P>A/2K%X;JR:-);NW,DN=B1V<CDXQDX5B0!D9/N*K7MK
M??V%?QR6<%P)3*$L=FWYLDKM.[YL\$CCOC'2M?48;J6^LC;;(PI?=.8]Y0X&
M%QD?*><_0?4 %.V6ZNRZPW]D[(%+[;=R!D9'._FJG]H9GV+J5FRC[SK:R$+D
MX!)W8"GG#$X./K6EI"2"^U*1[2*'S)$/FQG(F8* 6Z^O';H>O6LU[6_M]'.;
M2"61W 6T"[=A#Y 'S?.@Y./3D#M0!8OI)].0&YU&QC9@2H:W?G'KAS@9(&?<
M4^T2[O8V>*[M@4;:ZO:2(RG .""X(X(/T-6=2M;FXU&T,*Q*@20-*T>_KMPA
M&1\IP3]0.E+H_G%K]I;9(@UQE&5MPE&Q,MG)R,Y Z8  QQ0!E)J!DG$<>HV;
MJ2HWK:2%06.%R=V #V)//:K-\\^G(&NM1L8MP)7= _;J3A^!R,GWJNMK?6^E
MVBM:P2R-+%_HX7:8<2#./F^=%!8CTP"!V&IJEK<7-[9^2L:H!('E:/?C('RD
M9'RMSG.>5'U !5LUN[U&,5W;!D.UT>TD1E.,\AF!Z&J":LDMQ%#'J5JQE<Q(
M5L9CEQG(SG'&#W[5L:1YYN=0::W2,&8%9%;<)?D&6!R>,\8XQC%9<MMJ,8AU
M-X(I-0WX$* IL8_*3C=B0!2W)YQS[4 37TT^GO'%/?VBS3!C$GV61M^.OW6/
MJ*?I[7&J6:W=I?6KPO\ =8VDBY_ L#5S5(+N[N8+>/RUMBK.TC1[R'&-HX(*
M]^1SP.E)H0FBL9;<VXBAMW$5M\^\/&$7YMW<%BW)Y]J ,B#5EN;F"&'4K5S/
MD1$64WS$'GG....]6KZ6?3VB2XO[19)LB)?LLC;R!TX8U"MKJ$,EIJ+P1R7\
MCJKQH"GEAG42';NPX"@_-UX'6M75(+J[FM[>(1K;MN:21H]^&&-HZC'\7(YR
M!TS0!GVD\M[IS7\%_:FW0$LYM)%QCKP6!IJW$S7(A%]:X;: _P!DDV[F&0I;
M=@'!7 SGFK6DQ3IIUY9FU3R828[<,^]9@4!)+$DD%BPYYJC;:?<Z?;6:I:QS
M--<Q2R1X*^21M5FVEB"%4 #'0@'!ZT 6+MKFT+(]]9^:$WA/LTASDA1T8\EB
M!@<\T*\[64UV;ZU6& ,9=]I(K1X&3E2^0<<XQWJ;5],DU#5+1ECC5(UWB8J2
M=ZLK*IPPPN1GZ@?B6J7$^FZLK6$.97?RHV;<EP#&O);/*ELCMP ,#% %=9;@
MWIMOMMKNW;%;[+)M+8Y7=NQN]LYI;I[FU:2-KVT\Y%5O+^S2$G<2% PQR25/
M YXJ.VL9]/:PCC@2<2W/G.2"IBRIW,4+'V (Z9Z<YJUJ6F2WNM03+'$BPQK(
MLS*26=6)"L0PP!G(ZYR?3D +:WN;Y$D6\MVB612ZBV=7!5@2I!;@\=Q6Y69H
MAE-M.9;80 W#E &W;U/\6[)SGGGTQTK3H **** "BBB@ HHHH *Q?$]]-I^F
MQSPSF$"8"0KC>R8)(7*MSQGIT!Z=:VJSM6TZ74DCC6:%(U.XB2%G.>G!#KC@
MD'U!- $'AF>.;1D2(S;(&,(68 ,FWC;@*O3Z5DV&K,-9C:>ZMWADGFM8I70"
M4X9CL.). -IYV]AD#-:NAVMQ::3-&(1%,78QM+N)?@ ,P+$CIC&>@'2LVPTB
M[.M-)J]C!(C*&1X(X_*\SYMQ;@/TVXSGG- %GQ,7\ORQJ,D,<RF.2$0^8I4C
MGHC$9SW-:&CR75SH4#W)>.Y96!9EYZD!L$#J,'! ]Q5BYTZTNRS36T#RE=HD
M>)6(].HJNVFR6^@RV%C.RR^6PCE8X(8Y/;IR>PX[=* ,71Y)SJ-F9[RZGNB&
MCN%:%4954/M\S Z9/8]2.HJWXLNY+6VMD$K+!,[1S)& 7=2I& "K<9(SQWZ^
MK[*PD34+:2WTUM.CCW>>3*I\X%2 ,*3GG!W-@\>YJQK.E2ZF /.A$2*1L:%F
M8Y!!Y#KP0>E $NAW*W>C6\R/(P(*YE #<,1@X5>F,=!6%INK-_;$33W5O)%-
M++;12L@$K;2S;#B0XQ@\[>W.,UM:3#<0:$L:Q+#<XD*B4ELL68AFY)R<[B,G
MJ>:R=/TB[_MIY-7L8)$90T;P1Q^5YGS;B> _]W&<\T 3^)B^SRQJ4D4<Z&.2
M 0^8I4C!^ZC$9SW-:6DR7=UH<#W)>.Z=#EF7G.3AL8'L>0/I4]UIMG=[FEMH
M&E*[1(\2LP].HJO)ILL&@26%C.RRB,JDC-@Y)SU'W>I' X[=* ,719+@ZA9&
M>[NI[ID,=PK0JC(%#;?,XZ98]#U(ZBK7BR[DMX+:/S66WG+QS1Q &1P1@8!1
MN,G!X'4<^LEC821ZC;RV^G-IT48;S\R*?.R, 84G//.XX/&.YJ?6=*EU+!\Z
M$1HA 4PLS<C!P0Z]>./4"@"?1;E;S1K>=7D<,I&Z0#=P2.<*.>/05A>'M6:6
M]MOM%S;R?;+?]S*$ DF5.A;$C8/S'C'4]CQ6O80WL/AY8X(HX+S#E1.68%BQ
M.YN2<G.3R>3U-9VBZ1-#J<SZE8Q[@P:W>..+RE&%S]T!L[LXW#ICGK0 _P 3
M;]OE#4I(HIU*20"'S%(Q_LHQ&<]S]*T]+DN[K0K=[@O%=/'\S,HR#ZXP/KR!
M]*FNM-L[O>TMM TK+M$K1*S#TZCM5>7398= >PL9F601[4=FP3SDC(^[GD9'
M3/'2@#'T26X:_LC/=W4]RT.RY5H50IM!V^9QZLW0]3W'-/\ %EY)#/:V[2R_
M99D</%  79@5VG!1N.OISCK5NQL)(]1@EM]/;3H45A.#(I\[(X&%)!P>=QP>
MW<TNM:3/?.TXFC"QK\BI"YDZAN&61<G<H(]"!0!HV%PMUI-M<K(SK+"KASU(
M(SG@#G\!]*Y[P[JK2WEN+BYMY#>6P:*4(!).J8P6Q(V#\W3'4]NE;5O#>0^'
MH8;6&"VNT@55CD)9$.!P<')K*T329H-2G?4K%-ZMFWDCCB\I1A<XV@'.[=C(
MZ=^M #/$K3++Y<>IRJK8?R/(\P*RD%>5C8CD \FMDF[N/#RL&EM[Q[8,<*&=
M'VY(P>,YI]YI-G>+(6MX%F<?Z[R49A[_ # Y_&HKZPE_L5+*S9CY0C7:TA#2
M(I&5+=02 1GWH S=!E=]1#&YGN'EMM]P3$$5)!L&'^4?-@''T;BH_%=[)!=6
MUN\LOV:6-BT4 !<N&4J2"C<<'TY]:T-,LY(M1,T-BVGVGE%&@+J?,?((;:I(
M& ",YR=WL*CUK2)[UVN!,FV-?D1(7,G!#<,)%R=R@CTH MO>+)X9:]%Q(J-9
MF7SPH9@-F=V !D]^@K.\/ZD\M]+;W4MKY\\:W(\E1F08"[B1(PZ #'MP3S5X
M6]\OAV"WLX;6WN1"B&&;+QJ, %>.OIWJCX>TM[:>9[^Q"7*NWE2!(M@3/&W8
M!SCKD9H K^)7G28I%J<H!Q((/(W@.I!7!6-B.0#SS6U,;R?P\65IK>\:V#?*
MJM(K[<D 'C.>*?>:19WB2;K>!9I.LWDHS#WY!J+4+"4Z/':6C,PC\L%6D(,J
M*1E2W4$@=?\ &@#.T&5WU(M]IFN&DM_,G/E!%63Y%PWR@[L# ]@<BJGBC4FM
M=46*:>86RPI,J6X4LKJS-N;,;<84$<C[IX-:VF6<D.H--%9-I]IY11H"ZG>^
M00VU25& ",YR<\]!577-&N;HS70>.5@ $BCB=78<@ L)!_>89QT8T :VH3B/
M0[JX\]H@ML[^:HW,N%)W =R.M96@:B\M]/;W4EK]HF1;G$*CYP0%W$B1AT4#
M''3C-:=Y%>MI(AL4M8Y]JJ4G!:,+W''M69X=TM[:69[ZR"72NWER;(M@3)V[
M=@'..N0#0!0\0S7<5VWV?4)IGC/G16X@W?/SA0RQ$#TY/UKH-<^U?V+<M9RS
M13JA93"@=SCL :2^T.QOH9$\B*)Y#\TL<2[^>N"1P3Z]:-8M9KFW@6*,S1I*
M&F@W[?.3!&W/U(.#P<8/6@"IH3@WUZ([F6XB8(YD\L)'O);<!P/FX&?;'2LS
MQ/J;6NK"*:>86R1).B6X4E'4L2S9C;L 1R.AXK:TFTE@NKB5;8V5HZH([4N#
MAAG<V%)5<Y P#VS5#7=%N;KSKH-'.V,)#'$ZLPY 4L) .C,"<=&- &EK=U]E
MT&XN5N3 516$H4-@Y&,@D#'KR!CN*J^'[UI);NSG:V6XC82M'   -Y9LYWMD
MDY/;'XBK>IV]]-IJ0V26H)P)8YQN79CD+QC/3&015/PUIS6L#/>6?EWX)#R%
M(P",G&W8 ,8QG@'UH S-?FNXKT_9]0GG>)O-AM_(W'?R-H98B!P2.3WY]:Z#
M7?M0T:X>SFFBG1=RF% [''8 TE]H5C>Q2)Y$4+R'+2QQ+O.>N"1P3Z]:-9M9
MKJ& 1QF>))=TUN'V^<FTC&>G4@X/!Q@T 5="8&\O1'<2W$1V/YGEA(R[%BV.
M!\W3/7J.E97B74VM=8\N>XF%O'&D\:VX4E&!8EFS&V.,$<CH>.];FD6DL%Q<
MR"V-G:NJ".U+AMK#.YL D+G*C /\.>]9VNZ+<W/G768[ACPL,<3JSCD!2PD
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M=VZ162VKQG/FI,H+'TVY!7.?4&F>';#[)IR&:T,-\5 N&9$!9L#.-G&W/3%
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MBEQD$R,R1E]_E(3PN[OC].G05?H **** "BBB@ HHHH **** "BBB@ HHHH
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7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $_ D # 2(  A$! Q$!_\0
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MHH *I76H&WNX[=(&E=T+Y#   $#O]:NUCWO_ "'8?^O9_P#T): )_P"TIO\
MGR?_ +^+_C1_:4W_ #Y/_P!_%_QJ.B@"3^TIO^?)_P#OXO\ C1_:4W_/D_\
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MK8K'O?\ D.P_]>S_ /H2T /HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD+O-F^_F1_EP,]^<BK=^THUR#;&&_P!%;JV/XEK<K'O?^0[#_P!>S_\ H2T
M-WS_ //!?^^Z-\__ #P7_ONI:* (M\__ #P7_ONC?/\ \\%_[[J6B@"+?/\
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MQ_SUC_[X_P#KT;;C_GK'_P!\?_7J6B@"+;<?\]8_^^/_ *]&VX_YZQ_]\?\
MUZEHH BVW'_/6/\ [X_^O1MN/^>L?_?'_P!>I:* (MMQ_P ]8_\ OC_Z]&VX
M_P">L?\ WQ_]>I:* (MMQ_SUC_[X_P#KT;;C_GK'_P!\?_7J6B@"+;<?\]8_
M^^/_ *]&VX_YZQ_]\?\ UZEHH BVW'_/6/\ [X_^O1MN/^>L?_?'_P!>I:*
M,#Q-I=YJ>GQI"$ED23( &W QSU-:MM#<PVL,1DB!1 IPGH/K5JBH4$IN?5D*
M"4G+N1;;C_GK'_WQ_P#7HVW'_/6/_OC_ .O4M%661;;C_GK'_P!\?_7HVW'_
M #UC_P"^/_KU+10!%MN/^>L?_?'_ ->C;<?\]8_^^/\ Z]2T4 1;;C_GK'_W
MQ_\ 7HVW'_/6/_OC_P"O4M% $6VX_P">L?\ WQ_]>C;<?\]8_P#OC_Z]2T4
M1;;C_GK'_P!\?_7HVW'_ #UC_P"^/_KU+10!%MN/^>L?_?'_ ->C;<?\]8_^
M^/\ Z]2T4 1;;C_GK'_WQ_\ 7HVW'_/6/_OC_P"O4M% $6VX_P">L?\ WQ_]
M>C;<?\]8_P#OC_Z]2T4 1;;C_GK'_P!\?_7HVW'_ #UC_P"^/_KU+10!%MN/
M^>L?_?'_ ->C;<?\]8_^^/\ Z]2T4 1;;C_GK'_WQ_\ 7HVW'_/6/_OC_P"O
M4M% $6VX_P">L?\ WQ_]>C;<?\]8_P#OC_Z]2T4 1;;C_GK'_P!\?_7HVW'_
M #UC_P"^/_KU+10!%MN/^>L?_?'_ ->C;<?\]8_^^/\ Z]2T4 1;;C_GK'_W
MQ_\ 7HVW'_/6/_OC_P"O4M% $.VXP?WL?_?'_P!>M#3/^07:Y_YY+_*JO8U;
MTS_D%VO_ %R7^5 %JBBB@ HHHH *Q[W_ )#L/_7L_P#Z$M;%8][_ ,AV'_KV
M?_T): 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P _$OZ?X5-10!#Y#?\ /Q+^G^%'D-_S\2_I_A4U% $/D-_S\2_I_A1Y#?\
M/Q+^G^%344 0^0W_ #\2_I_A1Y#?\_$OZ?X5-10!#Y#?\_$OZ?X4>0W_ #\2
M_I_A4U% $/D-_P _$OZ?X4>0W_/Q+^G^%344 0^0W_/Q+^G^%'D-_P _$OZ?
MX5-10!#Y#?\ /Q+^G^%'D-_S\2_I_A4U% $/D-_S\2_I_A1Y#?\ /Q+^G^%3
M44 0^0W_ #\2_I_A1Y#?\_$OZ?X5-10!#Y#?\_$OZ?X4>0W_ #\2_I_A4U%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 =C5O3/^07:_\ 7)?Y54[&K>F?\@NU_P"N2_RH M4444 %%%%
M!6/>_P#(=A_Z]G_]"6M"YO;>T*B9RN[T4G ]3CH/>L^]YUR'_KV?_P!"6@!]
M%&#Z48/I0 448/I1@^E !11@^E&#Z4 %%&#Z48/I0 448/I1@^E !11@^E&#
MZ4 %%&#Z48/I0 448/I1@^E !11@^E&#Z4 %%&#Z48/I0 448/I1@^E !11@
M^E&#Z4 %%&#Z48/I0 448/I1@^E !11@^E&#Z4 %%&#Z48/I0 448/I1@^E
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MF\D\SYCQA>Y'?FNGTLQFU8QW$\P+'/G'++V_I5%;+[)>1)<:K>2R33$QC(
MQNVGCIQB@"MK26ND0"4Q73Q[6+.;IP%P.!UZG^AIVE6]O?02EA,WE8 DANW=
M).,\'C)]:U=2LWNTAV7TMJ$D!8H1\X/&TYHTQ%%LY2:XD4NRYG/(()!QQTXH
M YFVO+>XO1#Y4P?*(]O]MD,B[NX7T&>>>QJ[K:VNDQ*Q2Y,;*=TING4(<@#N
M?7/T!JW;V@M;R"*;5;RXE=F9,L-I .<-@>^/>KNI6;W1@*W\MJJ/\P0@"0'M
MSWH SM+M;>^MY'839C;:'CNI&23@'*GC/7'U%06=NTT<$MQIVH1><JG"7;,J
M9]<D$$=^*V=*,;6F8IYI06/,Q^9?;VJC'9FTO(8[C5KV:265C&-P P.=K<?A
M0 R]L!!=0PV]K=3K(CL[B[==N,8 R<9.>Y'2IK338)X6,D-_"R<8EN&R??AB
M*MZE9R70AV7\MH$<;O+(&\'C:<_I2Z8JBV+)-<2@NPS.?F&#C\N* ,6T@>:.
M&6?3=0C$@'$=VS!<^H)!!_"K%]8BWN((K>UNK@2!B["[==H&/?&3GOBGK:?9
MKN-9M7O)6FG/E@,,*,%MIXZ<$?E5[4[5[J.()?2VFR0%BA WCIM.?\YH IV>
MFP3QGS(;^%DX/FW#9;WX;%8LMW$EP1]GG 7/[MKR0.W.-H']_OC/0BNETOR_
M*D\NYGFPY4^>P+#!(_+@U2>R^S7:_:-5O&,\Y\I0P 3@M@\=.#S]* *^K0V^
MG1J4ANY-R,V?M+CICY1R<L<\#V-.TJVM[^&5F$W[IMN^*[=TDX!X/'T/O6GJ
M5G)=>04OYK4(_P PC(_> \8.?TIVF*@M-R37$BLQYG^\,''ITXH Y@741N47
M[/.,[1Y1O)-YW'& .[CJ1G@$5HZM!;Z=&A2&ZEW!CG[2X''\(Y^\<\"ITLQ;
M7<2S:M>3--,WE@,, 8W;3Q[8J]J=H]TD.R_EM-D@+%"!O'3:<T 96D6]OJ$4
MF\3?NL#S([MV5^/7CD=ZS&N@;Q?*M99(0&\R-;V3S8\,!AEQP3V&:Z?2_*\F
M3R[B>;YR#YQ!92"1^7%4S9?9;Q!/JMX[3SGRE# !1@MM/'3@\_2@"'5+>UT^
M.(CS09"0))KN1(TXS\S9.,]JBT2!;^W;[5;74,B*IR+J1@V1ZG'/'IW%;.IV
MCW<,82]EM-L@)9,?,.FTY]?YTFF1JL,C+/<RC>R_OSR"I(...G% ',1W(EO8
MQ':RR0,!O5+V0R1$L!AEQPW.<9Z UI:M!;:>L:KY@:0-B2:[D2,$=BW/)SQQ
MV-3Q68M;N))M6O)GEE8Q@,,8'.&P/PJ[J=H]TL.V_EM D@+;"/G!XVG/Z4 9
M6C6R:A:%KJVNH)4"Y'VF1@<@'J<<]CQ5!9XV=7,;9)V_9!?2>?UQRGK^-=)I
M?EFW?R[B>7YR#YQ!92#C\N*RKC3&MK5+6.^>.]N9"IF+%M_5LL,\' /([T .
MU2W@L!"$67]Z2#+-=R)''@=SSU[4:5:V]\LBN)CY6T":*[=XY,CL>,D=ZTM1
ML%O'MC+*1#&WSQERH?/ Y'<'I4>E02BYN[@W,DD#$11)(""FPL#GUR>_IB@#
M :>,.7\MOE++]D^W2>>W./N>O'KWK2U2VM[".$HLQ\UBIDENY$CCX)RQYQTQ
M3+G33!:/!%?NE[=R-&)]Q;.<M\PSQ@ C(]JU-2L5NUMO-FVPQOET+%0_&.2/
M<YH S-)MH+[S(W\UO*"_OX;MWC?.> >.1CGZBF" /=2QII>JD1.4)-T K>C#
M+\BM#2HV^W7<HNVD@PL4<3_>3:S D^N<\'T%4KW36M[2:)+Z2.]O)'C2?<3]
M[)&X9XQT!'H* )]0L;>QMQ*EM?W.7"E(;ALC/?EAQ2V6F1S*PGMK^ KC!ENB
M2W_?+&KFHV0NX8%DF*Q12!I%W%0XP1@D?7/X5#IL$@U"[F%S*]L%6"..0'*%
M2V3D]1R.?:@#.C@$UPZKI>JA8W,9+70 /^U]_)&*LZA906,4;QVNH7.]PA$-
MPV5SW.6'%07&FF"S^S0Z@Z7MU(T?G[BP;JWS#/!P",COBM34;%;LVQEF*PQO
MET+E0^1@<CWH JV>EQS1GSK>^@*X \VZ)+>_RL:S)2(+*YOY;.Z\F'>%C2[D
M+D@\;AVSCMGK6OI4;F]NYOM;2PD+%'$_WH]A8$GUR>A[@52O--:VM)88[^2.
M]O)'C6<L6!W9(W#/&!P"/04 2W]C';+;BWBGD>9]F9+N143@G)(SZ8'N:98V
MMO/>S64D5Y')!$C,S7+G<6+=#G!^[U]ZTM2L1>1VXDF*Q12!I%W%0XQC!(^N
M?PJ'3(9!?74XN)'ML+#''(#E"A;)SWSD<^U &1,!!;7=[):77D6WF (EW(7)
M7H67L#C(QG@U=O;*.W@MV@BGDDF<)\]U(JID$Y8C/ICZD5'>:?Y%K<K'?NE[
M=R/&D^XMC=G 9<\ =./05IZA9"ZMH$DFVQQ.&D!8J)  1@D?7/U% &;9VL$N
MH26,L5XDD,2R,[7+D$DD8!S@]*J7&%>=HK.Y\FW+[VDO'7=MP,8Y.3D%?6M;
M38F&JW3I=N]NB+"D+YRI!))SW'(P?:JU[I_V6"Z?[9(EW<R%(IMQ.-_"@KG&
M!G''I0 E];V]I! \=O>2O,<!/M+KCC."<]>P]Z33+*.YDE@N(KB.2%5)873L
M/F&<$\?,.X]Q5^[T[[1;6:37!\N CS 7*B3C')'/7FFZ7#*+RZG^TR26Y AC
MCD!W(4+ G/?.>OH* ,69@IFFCLKKR("P8O>."V#C ')W'L.X-:.H6=O911-'
M#=S/*X15^TNH!P3R<\=,?4BHKS3C!:3QQW[I>W<CQI/N+#YLD;AGC'3(]!6I
MJ5D+N&!9)ML4<@:12Q4.,$8)'US]10!EZ9:)<RR07$5S&\:(^1=.WWL_*W3#
M#'(]Q5"^DDM+]+?^SYQOG$4>^_<"4'^(=>GIUK;TR)AJ=W(EV\D"JL*0OG<A
M4MDY[@Y&#[54O]-%O;7)^V.EY<RLL4Q);;OSM!7/09QD>E $VHZ>MI:>=;6U
MU=."-T8NW7 [GKSCTJIH<4>J+<F2*9$AE\M76]=]YP"?3'7%:U]8FYLK>*2<
MJD3*TN6*B0 8()'/O^%0Z=:LFJW,D<\AMHU$(B<'(;[Q.>XP1SUH Q-2D>QO
M%A_L^?!G2*(M?NHF#$#(Z],].O%:U_IRVMD9K>VN;F48S$+MQQW.<\XJ.\L%
MMXKJ4WC"ZFEVQ2Y+;2QPH*YQ@9[=JNW6GM-I=O;RW) BV&5BQ42 #D$]<'K0
M!E:)%'J;78DAF1()?+#K>NQ8X#=.,8W8_"H)98/MDEM'%.DL!D=Q+=R*#&N!
MD=<YW9'TZUK6-OLUJ8PW3?9X4,7D-G.X[6W ]Q@@?G3+NR%I]JNGNW6>:0"*
M3<3MW84*5SC:": *]\+.PL+>\D@OO+EY<>>^Z,;"W//J /QI=,M8KIVBF6<$
M1K()$NY&!#9P">/F]O>KTNFO)I5E;W%T6%OL,S%B!* N#DYS[_A2:=;R+J=U
M*MQ(ULBB!(I <JP)).3U'(Y]J ,62> SRQ1PW"R6XD>5)+N1<HK%1CU)X(^H
MJ_?PV>GVL%P\5Z8Y&P_[]\QC:3D\^H _&B\L1;P73B]=;NXE*1S!BVW?PH9<
MXP,]NPJ_>6!GTZWAEN"%B*F4EBHD '()ZX[_ (4 9FEV\5XPCE2<!HA,CI=R
M,-K= W3!KHH84MX$AC!"(H503G@5E6$)&L3F.[=K>&/R1 ^<AN&R#W&"!^=;
M% !1110 4444 %<'J\QM?%,\BV\,BM+&29PI;("#Y,J3T.1SU#8KO*Q[K0D=
MDDM)98IO,#&1IG; SS@$XS0 >)4>320$MY)CYR$^7G>@S]X8(.1]:@\-73R1
MW5L\=R1#*0LLP;]X,#U)P<YX_'%7=6T=-6C16N9XM@. C?*V?[RG@U)H]@^F
M:9#9,T;B%0BM&FW( ZD9ZT <G=6L/]L130:>;)/M,9$[H57[PR-NS'/3KWK>
M\416TMA")DCDE697BC8$E\$$A0.<XS6O+;PSF,RQ*YC;<FX9VGU%5KVQDGN(
M;JWG$-Q"&569-ZE6QD$9'H.] %/PX$,%U+%%%#')-E8E^^F% (?W_I7.ZG,;
M7Q5.ZV\,BO/&29PI?.$'R94GH<CGLU=A86)M#/))+YL]P^^1]NT9    [# J
MG<Z$A>.2TEEBE$@8N\SO@ \X!.* '^(D>30YUCMWG;*?(F=P^8<C!!R.O7M5
M'PW<OYUY9NEVZQL"LTX;Y^!D<DX_3/I6IJFEKJD2(UQ/%L.X>6V WLPZ$>U-
MT337TC3DLB\3I$,(Z1["1ZL,]: .7FM8?[9@F@T\V4?VF,B9T*K]X<;=F!GI
MU[UN>*(K:6S@$T<<LJ3*\<3 EGP<D*!SG%;$MO#.T;2Q*YC;<A89VGU%5KVP
MDGN8;JWG$-S$K("R;U*MC((R/0=Z *GAP(;:YECBBBCDF)6-/O)P 0_OD?EB
MN<OYC:^+)G6WA=7N8\F8*7S\@.SY2<<@CGL?2NPL+$V8G>24RSW#^9*^W:"<
M # [# %4Y]"3S(I+266*19 S.\SOP#R "<<]/QH =XC1WT258[=YVW)\J9W
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M2*YDA9)( H=P=C,1QP.>3VK3G@BN86BGC62-NJL,@U7OK!;R"-5<Q20N)(G
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-** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $_ C\# 2(  A$! Q$!_\0
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MT?V[!_SQ?_OY'_\ %T44 ']NP?\ /%_^_D?_ ,71_;L'_/%_^_D?_P 7110
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M-J3VK0H$6/>)%D)/)P,C'&<'N>E4X=::925MT#,X2)&D8,V20"<KP,#.1FM
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M[%/V+_='Y4;%_NC\J &?:(/^>T?_ 'V*/M$'_/:/_OL4_8O]T?E1L7^Z/RH
M9]H@_P">T?\ WV*/M$'_ #VC_P"^Q3]B_P!T?E1L7^Z/RH 9]H@_Y[1_]]BC
M[1!_SVC_ .^Q3]B_W1^5&Q?[H_*@!GVB#_GM'_WV*/M$'_/:/_OL4_8O]T?E
M1L7^Z/RH 9]H@_Y[1_\ ?8H^T0?\]H_^^Q3]B_W1^5&Q?[H_*@!GVB#_ )[1
M_P#?8H^T0?\ /:/_ +[%/V+_ '1^5&Q?[H_*@!GVB#_GM'_WV*/M$'_/:/\
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M_='Y4;%_NC\J &?:(/\ GM'_ -]BC[1!_P ]H_\ OL4_8O\ ='Y4;%_NC\J
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MO@3C*\_SQQ5@V[I///&X,DH10&'"A<\?J?SJFNC;=I6X^:$ 6YV#]V <X/\
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ME[*/S-G1_"]UI>N1W)FCD@13\V""21C&*YA8S<>(3!EBKW9! _WJ]+^R6_\
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MC1]FC]9/^_K?XT 345#]FC]9/^_K?XT?9H_63_OZW^- $U%5Y(H(HGDD9U1
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M'4%Y_P >-Q_UR;^1K:3[B_2N?N[:,65P<R?ZMO\ EHWH?>N@3[B_2@!:***
M(([N"6=H4<EUS_"0#C@X/0X[XZ5%_:EF1)B4G80"!&V3DX&WCYN>.,U5M-,E
ML+F2:((R_.<!B&D+ON^;/]WD#Z]JC72+A/)(>(FT 6W&3\P!_BXX.,#C/K[4
M 7UU.S9HE67)EQM.QL<G R<<$D$8.*H/_P AR]_ZY0_^STL>D3QL!OC*2.DL
MQR<AED+X7V)..:AE@5M=OCND&8X3Q(P_O^] %JBH?LZ_WYO^_K?XT?9U_OS?
M]_6_QH FHJ'[.O\ ?F_[^M_C1]G7^_-_W];_ !H FHJ'[.O]^;_OZW^-'V=?
M[\W_ '];_&@":BH?LZ_WYO\ OZW^-'V=?[\W_?UO\: )J*A^SK_?F_[^M_C1
M]G7^_-_W];_&@":BH?LZ_P!^;_OZW^-'V=?[\W_?UO\ &@":BH?LZ_WYO^_K
M?XT?9U_OS?\ ?UO\: )J*A^SK_?F_P"_K?XT?9U_OS?]_6_QH FHJ'[.O]^;
M_OZW^-'V=?[\W_?UO\: )J*A^SK_ 'YO^_K?XT?9U_OS?]_6_P : )J*A^SK
M_?F_[^M_C1]G7^_-_P!_6_QH FHJ'[.O]^;_ +^M_C1]G7^_-_W];_&@":BH
M?LZ_WYO^_K?XT?9U_OS?]_6_QH FHJ'[.O\ ?F_[^M_C1]G7^_-_W];_ !H
MFHJ'[.O]^;_OZW^-'V=?[\W_ '];_&@":BH?LZ_WYO\ OZW^-'V=?[\W_?UO
M\: )J*A^SK_?F_[^M_C1]G7^_-_W];_&@":BH?LZ_P!^;_OZW^-'V=?[\W_?
MUO\ &@":N3U_Q1<:?J,EI:+$=B ,S DJQYX_#%;6JW$6F:?+<L\C,@^5/.8%
MCT'>N-T;0KS4[J&]FCW6K2;I&9P"W//OUKCQ-2=U3I[LY,1.5U"&Y!>>(=4U
M2,6KRJ$?"E(UQO\ K2:IX?N=)LHY[EX\O)LVJ<]L@Y_.MVT\(7$9A>2:)7CN
M/,;:2=R<8 ]#P:ZAK2)QAS(P]&D8_P!:YX8651-U=^AC##RFFZF_0YFSTRZ;
MP-+;I#NFG/F(@ZD$KCK["F:MH@M_"ENL-NPN$9'D5068L1@]/\\5U0MD P'E
M '82M_C2_9U_YZ3?]_6_QKK^K1<;>5CI^KQY;>5CS+3[95U^VMI5#K]H5'5A
MP>>016GHVHQZ'K=Y#<RE+8%U*QC<"P/'Z9KJ)/#EA+J27Q\U95(.%? )SG)[
MY_&N.\4V4=EK;B,DB51*0>Q).?Y?K7#.E.@N==&<<J4J*YET9W\5[%<Z=]LM
M\O&49ER,9QG_  K,\,ZO/J]I,]RT?FH^,(,84CCC\ZS$F:R\"17$3,)&&W!D
M;'+$' S6'X<FGBUJW@CEDC29PLBJ<;@,\5T2Q#4X7ZK7YF\J[4X>:_,])>1(
MD+R.J*.K,< 5A^*-2@AT.2-949[E=J!3G(SR?I69XSN)+>."T1V\J8%GW.23
M@\#DUSAEDO8;*V"R2O%N  R3MR. /;!_.EB,39RII"KXBS=-'5^"[WS+*6UD
MG#/&V8XR>0F.WMDUU->>W,)\,^(UD(+0-ED$;%24.1CKQC^E7[3Q4D\=R+F,
MQ%8F:/%PWS'LN#WIT:\81]G4T:'1K*"Y)[HC\67$FHZM!IUL"[1@G:/XF(SQ
M^%:'A77(KBWATUT*SQ(0&XPP']>?TK+\'Z:9[V2YFBD6-$^1P2O)XX]>,U5U
M#0KK1)H[QI4\H7 ",I)8#.03^581E43]O;??T,5*:?MK;[^AW>I7"6NFW,T@
M8HL9SM&3SQ7+:!X<M-0TFWNK@.L@D)^4\.H/0_D>E3^)[L26=O:V$[3&ZDV$
MK*6!Z?+UQU(K<TW35LM.@MRT@9$&X+*V-W?OZUUM1JU;-727XLZ6E4JV>J2_
M,T**A^SK_?F_[^M_C1]G7^_-_P!_6_QKK.HFHJ'[.O\ ?F_[^M_C1]G7^_-_
MW];_ !H FHJ'[.O]^;_OZW^-'V=?[\W_ '];_&@!T\8FMY(CT="OYBJ&@Z;+
MI.F"UED1V#ELIG'/UJ[]G7^_-_W];_&C[.O]^;_OZW^-2XIR4NI/*N;FZDU%
M0_9U_OS?]_6_QH^SK_?F_P"_K?XU107G_'C<?]<F_D:VD^XOTKG[NW465P=\
MO^K;_EJWH?>N@3[B_2@!:*** (([RVFG>".>-Y4SN16!*_44P:C9'S2+N B+
M_6?./EYQSZ<\55M[>>TN9'6)Q#ER4$QD\QF8$$ _=QSD>_M5=-.NHMOE1E8X
M7#B%IRXD8'J"?N\$\>OYT :HO;4O$@N82THS&-XRX]1ZUF/_ ,AR]_ZY0_\
ML],BTRZC8*47;+(DKL'_ -5MD+[1QSUQ22Q,VNWQ$\B_NX> %_V_:@"S147D
MO_S\R_DO^%'DO_S\R_DO^% $M%1>2_\ S\R_DO\ A1Y+_P#/S+^2_P"% $M%
M1>2__/S+^2_X4>2__/S+^2_X4 2T5%Y+_P#/S+^2_P"%'DO_ ,_,OY+_ (4
M2T5%Y+_\_,OY+_A1Y+_\_,OY+_A0!+147DO_ ,_,OY+_ (4>2_\ S\R_DO\
MA0!+147DO_S\R_DO^%'DO_S\R_DO^% $M%1>2_\ S\R_DO\ A1Y+_P#/S+^2
M_P"% $M%1>2__/S+^2_X4>2__/S+^2_X4 2T5%Y+_P#/S+^2_P"%'DO_ ,_,
MOY+_ (4 2T5%Y+_\_,OY+_A1Y+_\_,OY+_A0!+147DO_ ,_,OY+_ (4>2_\
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MQ_SUB_[]G_XJ@"6BHMMQ_P ]8O\ OV?_ (JC;<?\]8O^_9_^*H EHJ+;<?\
M/6+_ +]G_P"*HVW'_/6+_OV?_BJ ):*BVW'_ #UB_P"_9_\ BJ-MQ_SUB_[]
MG_XJ@"6BHMMQ_P ]8O\ OV?_ (JC;<?\]8O^_9_^*H EHJ+;<?\ /6+_ +]G
M_P"*HVW'_/6+_OV?_BJ ):*BVW'_ #UB_P"_9_\ BJ-MQ_SUB_[]G_XJ@"6B
MHMMQ_P ]8O\ OV?_ (JC;<?\]8O^_9_^*H EHJ+;<?\ /6+_ +]G_P"*HVW'
M_/6+_OV?_BJ ):*BVW'_ #UB_P"_9_\ BJ-MQ_SUB_[]G_XJ@"6BHMMQ_P ]
M8O\ OV?_ (JC;<?\]8O^_9_^*H EHJ+;<?\ /6+_ +]G_P"*HVW'_/6+_OV?
M_BJ $O/^/&X_ZY-_(UM)]Q?I7/W:W'V*XS)%CRV_Y9GT/^U70)]Q?I0!SOBK
M2[G6%AM8-'TV[4@DW%\QQ"?]D*-Q)]B.E3^%M"N?#^F/:W.I2WS-(74ONQ&,
M ;%W$G;QW/>JWCK>/#9D2]6T$<T;NQNS;;USRHD'0FL+P+#?7&H?VA!JAN+
MF5)HCJ9NQ&<)L7)&-WWCD=B!S0!Z%16);3W@UIY;R&>"$P'AF4QKAP!C!/.#
MU/\ 2JB&? WM<;,+]NY?AMW.WVZ_=[8H Z:L5_\ D.7O_7*'_P!GJK#]I\V'
M>UQYF^/[-DOS'YAW;NV=F/O<]*EE,_\ ;M]M2,CRX<9<C^_[4 6J*BS<_P!R
M'_OL_P"%&;G^Y#_WV?\ "@"6BHLW/]R'_OL_X49N?[D/_?9_PH EHJ+-S_<A
M_P"^S_A1FY_N0_\ ?9_PH EHJ+-S_<A_[[/^%&;G^Y#_ -]G_"@"6BHLW/\
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MYS_ABM6HLW/]R'_OL_X49N?[D/\ WV?\*[8148J*Z'7&*BE%')Z1_P CY?\
M_;3^8K8\5/L\.W/S[2Q5>O7D<50D:6/QW%\B;Y+?&-QQT/?'M61K^KW-U+>:
M;.4PDZB,*.F,]^_45P.:ITIQ?5M'$Y*%.47W9FV[S:I]@TK<559" >H^8YSC
MVYKL-9\."ZTZSM[)4#6Y"Y<XRO?\<_UJEHGAF[T_5#<3!"(O]4PDP&R,'(P3
MWKJ<W/\ <A_[[/\ A3P^'O!^T6K_ "0Z%"\'[1;E>UTJULKR>Z@5E>8 ,,_*
M .F!VJ[46;G^Y#_WV?\ "C-S_<A_[[/^%=ZBHJR.U)+1$M%19N?[D/\ WV?\
M*,W/]R'_ +[/^%,9+146;G^Y#_WV?\*,W/\ <A_[[/\ A0!+146;G^Y#_P!]
MG_"C-S_<A_[[/^% $M%19N?[D/\ WV?\*,W/]R'_ +[/^% $M%19N?[D/_?9
M_P *,W/]R'_OL_X4 2T5%FY_N0_]]G_"C-S_ '(?^^S_ (4 2T5%FY_N0_\
M?9_PHS<_W(?^^S_A0!+146;G^Y#_ -]G_"C-S_<A_P"^S_A0!+146;G^Y#_W
MV?\ "C-S_<A_[[/^% $M%19N?[D/_?9_PHS<_P!R'_OL_P"% $M%19N?[D/_
M 'V?\*,W/]R'_OL_X4 2T5%FY_N0_P#?9_PHS<_W(?\ OL_X4 2T5%FY_N0_
M]]G_  HS<_W(?^^S_A0!+146;G^Y#_WV?\*,W/\ <A_[[/\ A0 EY_QXW'_7
M)OY&MI/N+]*Y^[-Q]BN,I%CRV_C/H?:N@3[B_2@#E_&\=U<:=##;VT[%9HY4
MFADA4K(& 5?WO&3G^G>G^"9;N;2KAKR261Q<%09'@8\  C,/R]<]>:3QZMLW
MAU1<&X#FYC$!MW1&$N?E^9_E4=>3T^M1> 8["+3;Y+*WDMF6ZVS0M(D@1@B
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MR_=8(,C\:M$ C! (/8U#YLW_ #[-_P!]K1YLW_/LW_?:UUI);'4DEL2@ #
M ],4M0^;-_S[-_WVM'FS?\^S?]]K3&345#YLW_/LW_?:T>;-_P ^S?\ ?:T
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M-=,H@@^UJ9U#DAR%(/.2>G>K[^$M90F19T=TY3$IR3GG!/2NV$KJH46T@ X
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M 2T5%YLG_/M)_P!]+_C1YLG_ #[2?]]+_C0!+147FR?\^TG_ 'TO^-'FR?\
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M #[2?]]+_C0!+147FR?\^TG_ 'TO^-'FR?\ /M)_WTO^- $M%1>;)_S[2?\
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M FR?6C)]:A^UV_\ SWC_ .^J/M=O_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\
M[ZH^UV__ #WC_P"^J )LGUHR?6H?M=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?
M6C)]:A^UV_\ SWC_ .^J/M=O_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^
MUV__ #WC_P"^J )LGUHR?6H?M=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]
M:A^UV_\ SWC_ .^J/M=O_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__
M #WC_P"^J )LGUHR?6H?M=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^U
MV_\ SWC_ .^J/M=O_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__ #WC
M_P"^J )LGUHR?6H?M=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^UV_\
MSWC_ .^J/M=O_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__ #WC_P"^
MJ )LGUHR?6H?M=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^UV_\ SWC_
M .^J/M=O_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__ #WC_P"^J )L
MGUHR?6H?M=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^UV_\ SWC_ .^J
M/M=O_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__ #WC_P"^J )LGUHR
M?6H?M=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^UV_\ SWC_ .^J/M=O
M_P ]X_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__ #WC_P"^J )LGUHR?6H?
MM=O_ ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^UV_\ SWC_ .^J/M=O_P ]
MX_\ OJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__ #WC_P"^J )LGUHR?6H?M=O_
M ,]X_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^UV_\ SWC_ .^J/M=O_P ]X_\
MOJ@";)]:,GUJ'[7;_P#/>/\ [ZH^UV__ #WC_P"^J )LGUHR?6H?M=O_ ,]X
M_P#OJC[7;_\ />/_ +ZH FR?6C)]:A^UV_\ SWC_ .^J/M=O_P ]X_\ OJ@
MO"?L-Q_UR;^1K:3[B_2N?N[JW-E< 3(28V_B]C70)]Q?I0 M%%% $#VW[Z6>
M-RDLB(A/4 *21Q_P(U VEQNQ=IYS(,>7(6!:/G/&1_/-2PWBS7MQ:B.16A56
M+,,!MQ8<?]\FJ:ZTK;0MNV90#;C</WH)QGV]?I^5 $RZ3 CQD22X4@LN1B1@
M2P+<=<DGC%5'_P"0Y>_]<H?_ &>IDUE)&3%N^W<J2DL/W;,Q0#'?YACBJ\CH
M-<O074?NH>I_WZ )\GUHR?6F^9'_ 'U_[Z%'F1_WU_[Z% #LGUHR?6F^9'_?
M7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7_OH4>9'_ 'U_[Z% #LGUHR?6F^9'
M_?7_ +Z%'F1_WU_[Z% #LGUHR?6F^9'_ 'U_[Z%'F1_WU_[Z% #LGUHR?6F^
M9'_?7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7_OH4>9'_ 'U_[Z% #LGUHR?6
MF^9'_?7_ +Z%'F1_WU_[Z% #LGUHR?6F^9'_ 'U_[Z%'F1_WU_[Z% #LGUHR
M?6F^9'_?7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7_OH4>9'_ 'U_[Z% #LGU
MHR?6F^9'_?7_ +Z%'F1_WU_[Z% #LGUHR?6F^9'_ 'U_[Z%'F1_WU_[Z% #L
MGUHR?6F^9'_?7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7_OH4>9'_ 'U_[Z%
M#LGUHR?6F^9'_?7_ +Z%'F1_WU_[Z% #LGUHR?6F^9'_ 'U_[Z%'F1_WU_[Z
M% #LGUHR?6F^9'_?7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7_OH4>9'_ 'U_
M[Z% #LGUHR?6F^9'_?7_ +Z%'F1_WU_[Z% #LGUHR?6F^9'_ 'U_[Z%'F1_W
MU_[Z% #LGUHR?6F^9'_?7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7_OH4>9'_
M 'U_[Z% #LGUHR?6F^9'_?7_ +Z%'F1_WU_[Z% #LGUHR?6F^9'_ 'U_[Z%'
MF1_WU_[Z% #LGUHR?6F^9'_?7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7_OH4
M>9'_ 'U_[Z% #LGUHR?6F^9'_?7_ +Z%'F1_WU_[Z% #LGUHR?6F^9'_ 'U_
M[Z%'F1_WU_[Z% #LGUHR?6F^9'_?7_OH4>9'_?7_ +Z% #LGUHR?6F^9'_?7
M_OH4>9'_ 'U_[Z% #LGUHR?6F^9'_?7_ +Z%'F1_WU_[Z% $=X3]AN/^N3?R
M-;2?<7Z5AWDB?8KCYU_U3=QZ&MQ/N+]* %HHHH KO;'SY;B)RLLB(F3R %+'
MI_P(U5&CQ*/EFE!3 A/R_N0#G"\?SSQ6E6='K,$T;R1Q2LJOL4KM.]LXP!G/
MOSCB@!4TB%'0B67:"K2+\N)&#%@6XZ[CGC%4I8HVUV])C0DQ0]5'^W5Y=7MW
M:,*LN'(#-MXC))4!O0Y!%5'_ .0Y>_\ 7*'_ -GH =Y,7_/*/_OD4>3%_P \
MH_\ OD4_!]*,'TH 9Y,7_/*/_OD4>3%_SRC_ .^13\'THP?2@!GDQ?\ /*/_
M +Y%'DQ?\\H_^^13\'THP?2@!GDQ?\\H_P#OD4>3%_SRC_[Y%/P?2C!]* &>
M3%_SRC_[Y%'DQ?\ /*/_ +Y%/P?2C!]* &>3%_SRC_[Y%'DQ?\\H_P#OD4_!
M]*,'TH 9Y,7_ #RC_P"^11Y,7_/*/_OD4_!]*,'TH 9Y,7_/*/\ [Y%'DQ?\
M\H_^^13\'THP?2@!GDQ?\\H_^^11Y,7_ #RC_P"^13\'THP?2@!GDQ?\\H_^
M^11Y,7_/*/\ [Y%/P?2C!]* &>3%_P \H_\ OD4>3%_SRC_[Y%/P?2C!]* &
M>3%_SRC_ .^11Y,7_/*/_OD4_!]*,'TH 9Y,7_/*/_OD4>3%_P \H_\ OD4_
M!]*,'TH 9Y,7_/*/_OD4>3%_SRC_ .^13\'THP?2@!GDQ?\ /*/_ +Y%'DQ?
M\\H_^^13\'THP?2@!GDQ?\\H_P#OD4>3%_SRC_[Y%/P?2C!]* &>3%_SRC_[
MY%'DQ?\ /*/_ +Y%/P?2C!]* &>3%_SRC_[Y%'DQ?\\H_P#OD4_!]*,'TH 9
MY,7_ #RC_P"^11Y,7_/*/_OD4_!]*,'TH 9Y,7_/*/\ [Y%'DQ?\\H_^^13\
M'THP?2@!GDQ?\\H_^^11Y,7_ #RC_P"^13\'THP?2@!GDQ?\\H_^^11Y,7_/
M*/\ [Y%/P?2C!]* &>3%_P \H_\ OD4>3%_SRC_[Y%/P?2C!]* &>3%_SRC_
M .^11Y,7_/*/_OD4_!]*,'TH 9Y,7_/*/_OD4>3%_P \H_\ OD4_!]*,'TH
M9Y,7_/*/_OD4>3%_SRC_ .^13\'THP?2@!GDQ?\ /*/_ +Y%'DQ?\\H_^^13
M\'THP?2@!GDQ?\\H_P#OD4>3%_SRC_[Y%/P?2C!]* &>3%_SRC_[Y%'DQ?\
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MM+Y;!1=B:;RQ [7DBJS,7R,\XQL'J?F'%:%A:M;7D4$VIWES.L6]MY 1QTZ
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M@[E)&/>MO1ED)NYVNWGCEE'E*X(:-54+@CUR"<\9S5&72Y+:UM[2*^F2\GD
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ML?8])*"07I62-B)!=R *P9% )S@9WD_13P:L:?8Q70F287*2P/Y;,E[*R,<
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G **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $Y CT# 2(  A$! Q$!_\0
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M\:/L=O\ \\__ !XU/10!!]CM_P#GG_X\:/L=O_SS_P#'C4]% $'V.W_YY_\
MCQH^QV__ #S_ /'C4]% $'V.W_YY_P#CQH^QV_\ SS_\>-3T4 0?8[?_ )Y_
M^/&C[';_ ///_P >-3T4 0?8[?\ YY_^/&C[';_\\_\ QXU/10!!]CM_^>?_
M (\:/L=O_P \_P#QXU/10!!]CM_^>?\ X\:/L=O_ ,\__'C4]% $'V.W_P">
M?_CQH^QV_P#SS_\ 'C4]% $'V.W_ .>?_CQH^QV__//_ ,>-3T4 0?8[?_GG
M_P"/&C[';_\ //\ \>-3T4 0?8[?_GG_ ./&C[';_P#//_QXU/10!!]CM_\
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M^O\ V4UL5CZU_P ?>E?]?7_LIH L4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1WHH[T 2Z7_R#+?\ W*MU4TO_ )!EO_N5;H **** "BBB@ HHHH ****
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M9N?D]1Z5C&*I\TI;HZYU'7Y(0V>K^5M#KRJYP%&!TXI-J^@I:.]<IZ)+I?\
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MFMBL?6O^/O2O^OK_ -E- %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWCF6-]&^P-'>EIR"&M[9IE^4YVN%_A/I4'P_MQ!8WQ$4D)>8,8?LC6\2?+_
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MO_930!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/O2O^OK_ -E-;%8^M?\ 'WI7_7U_[*: +%%%% !1110 4444 %%%% !1110
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M+0)#X?MRF<R9=L^M;-<N%P\5%59:R>M_4[\5B)7=&&D%I;T"BBBN\X HHHH
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MGVH Z^BBB@ K'UK_ (^]*_Z^O_936Q6/K7_'WI7_ %]?^RF@"Q1110 4444
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M2;1[_G1M'O\ G0!-I?\ R#+?_<JW532_^09;_P"Y5N@ HHHH **** "BBB@
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MB@ HHHH **** "BBB@ HHHH *.]%'>@"72_^09;_ .Y5NJFE_P#(,M_]RK=
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M\* +5%56OT52QM[L <D_9V_PH^W*?^7:[_\  =O\* +5%5!?H2P%O=Y4X/\
MH[?X4&_12H-O=Y8X'^CM_A0!;HJM]M7_ )]KO_OPW^%-74(W4,MO=D'O]G;_
M  H MT54&H1EROV>[W 9QY#?X4-J"(I9K>[ '?[.W^% %NCO57[<O_/M=_\
M?AO\*1=0C;.+>[.#@_Z.W^% &AI?_(,M_P#<JW573%9=-MPZLK;.588(JU0
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M'G^63-NW@8SN^7G@9'2MGP[?W,]S>6UX")5/G#)!PK$\ ACP/2HM1O[]-1N
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MIM(/8UMT4 86EPSP^$HH;&V43",A(KDX4\\YP.G7L*H>&]&-OJ<\UW:S0S1
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH P_$7A/2O%!LVU))R]F[/ \,S1,A88/*D'I6?<?#;PM<Z9:Z<^GLMM;+
M(J!)G4D2??W$'+9Z\UUE% '+O\/O#LB72-;2XN7CE?$[C$D8PKKSPV.,BMS3
M-,M='T^.RLU988\XWN68D\DDGDFKE% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Dec. 01, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">2,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,615,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 361.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 01, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 2,615,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">361.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">361.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 2,615,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp238184_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp238184_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp238184_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp238184_exfilingfees.htm">dp238184_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp238184_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp238184_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238184_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238184_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238184_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238184_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238184_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238184_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-25-015556-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-015556-xbrl.zip
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M>@_+8&*.FHZ1V9:E!.ZUK5[G53/4L93+1DW(/GNSELM1*4&:97UG4@AS=#7
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<97,N:'1M4$L%!@     !  $ 1P   (8+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp238184_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">2615</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">2615000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">361.13</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">2615000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">361.13</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">361.13</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">2615000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
